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Data Curation Protocol 
 
Literature sources 




PUBMED search: ((“kidney disease”[ Title/Abstract] OR “renal disease”[ Title/Abstract] OR “kidney function”[ Title/Abstract] OR “renal 
function”[ Title/Abstract] or “CKD”[Title/Abstract] AND (“particulate matter”[Title/Abstract] OR “air pollution”[Title/Abstract] OR 
“PM2.5”[Title/Abstract] or “air quality” [Title/Abstract]) 
Web of Science search: (TS=(“kidney disease” OR “renal disease” OR “kidney function” OR “renal function” OR CKD) AND TS= 
(“particulate matter” OR “air pollution” OR “PM2.5” OR “air quality”)) AND LANGUAGE: (English) 
Cochrane Library search: ((“kidney disease”):ti,ab,kw OR(“renal disease”):ti,ab,kw OR (“kidney function”):ti,ab,kw OR (“renal 
function”):ti,ab,kw OR (CKD):ti,ab,kw) AND ((“particulate matter”):ti,ab,kw  OR (“air pollution”):ti,ab,kw OR (“air quality”):ti,ab,kw or 
(PM2.5):ti,ab,kw) 
Google Scholar search: ("particulate matter" OR inabstract:"air pollution" OR inabstract:"air quality" OR "PM2.5") AND (intitle:"kidney 
disease" OR intitle:"kidney function" OR intitle:"renal disease" OR intitle:"renal function") 
Passive smoking and household air pollution 
PUBMED search: ((“kidney disease”[ Title/Abstract] OR “renal disease”[Title/Abstract] OR “kidney function”[Title/Abstract] OR “renal 
function”[ Title/Abstract] or “CKD”[Title/Abstract) AND (“secondhand smok*”[Title/Abstract] OR “passive smok*”[Title/Abstract] OR 
“household smoke”[Title/Abstract] OR “indoor air pollution”[Title/Abstract] OR “household air pollution”[Title/Abstract] or “tobacco 
smoke”[Title/Abstract]) 
Web of Science search: TS=("kidney disease" OR "renal disease" OR "kidney function" OR "renal function" OR CKD) AND TS= 
("secondhand smok*" OR "passive smok*" OR "household smoke" OR "indoor air pollution” OR "household air pollution" OR 
“tobacco smoke”) 
Cochrane Library search: ((“kidney disease”):ti,ab,kw OR(“renal disease”):ti,ab,kw OR (“kidney function”):ti,ab,kw OR (“renal 
function”):ti,ab,kw OR (CKD):ti,ab,kw) AND ((“secondhand smok*”):ti,ab,kw  OR (“passive smok*”):ti,ab,kw OR (“household 
smoke”):ti,ab,kw or (“indoor air pollution”):ti,ab,kw or (“household air pollution”):ti,ab,kw or (“tobacco smoke”):ti,ab,kw) 
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Google Scholar search: ("secondhand smoke" OR "passive smoke" OR "household smoke" OR "indoor air pollution" OR "household 




PUBMED search: ("kidney disease"[Title/Abstract] OR "renal disease"[Title/Abstract] OR "kidney function"[Title/Abstract] OR "renal 
function"[ Title/Abstract] OR "renal failure"[Title/Abstract]) AND ("cigarettes per day"[Text Word] OR "cigarette 
smoking"[Title/Abstract] OR "active smoking"[Title/Abstract] OR "active tobacco"[Title/Abstract] OR "active cigarette"[Title/Abstract]) 
 
Web of Science search: TS=("kidney disease" OR "renal disease" OR "kidney function" OR "renal function" OR "renal failure") AND 
TS=("cigarettes per day"  OR "active smoke" OR "active smoking" OR "active tobacco" OR "active cigarette") AND LANGUAGE: 
(English) 
 
Cochrane Library search: ((“kidney disease”):ti,ab,kw OR(“renal disease”):ti,ab,kw OR (“kidney function”):ti,ab,kw OR (“renal 
function”):ti,ab,kw OR (renal failure):ti,ab,kw) AND ((“cigarettes per day”):ti,ab,kw  OR (“active smoke”):ti,ab,kw OR (“active 
tobacco”):ti,ab,kw or (“active cigarette”):ti,ab,kw) 
 
Google Scholar search: ("cigarettes per day" OR "cigarette per day" OR inabstract:"cigarette smoking" OR inabstract:"active 
smoking" OR inabstract:"active tobacco" OR inabstract:"active cigarette") AND (intitle:"kidney disease" OR intitle:"kidney function" 




Published articles in a peer reviewed journal (abstracts will be excluded) 
Cohort, case-control, or cross-sectional study 
Provides a measure of relative risk (RR, HR, OR, PRR, IRR) 
Available in English 
Time frame includes up to 05/20/2019 
Kidney disease outcome (incident CKD, incident moderate CKD, decline in renal function) 
 
Passive smoking 
Control group of non-smokers 
 
Active smoking 
Article must contain estimates based on an exposure of cigarettes per day 
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Study year, authors, journal 




Relevant statistical methods 
Measures of relative risk and error (95%CI or standard error), and corresponding unit of increase of exposure (as appropriate) 
 
PM2.5 
PM2.5 range (median or mean, IQR or SD, range) 
 
Data selection 
In the case of multiple outcomes, priority given to models using a CKD outcome defined by <60 eGFR . 
Priority given to results that provide multiple estimates by pm2.5 range. Priority given to models that are presented as the primary 
analysis (ex: in the case of sequential adjustment, results selected from model reported as the primary one) 
 
Risk of bias assessment 
Scoring metrics 
Cohort studies will be assessed using the New-castle Ottawa scale for cohort studies (max 9 points) 
Case-control studies will be assessed using the New-castle Ottawa scale for case-control studies (max 9 points) 
Cross-sectional studies will be assessed using an adapted New-castle Ottawa scale for Cross-sectional studies (max 10 points) 
These scales have been described in detail elsewhere. In brief, these scales assess risk of bias from study design components such 
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Protocol specific score components 
All studies 
Adjustment by age, diabetes, and hypertension 
 
PM2.5 
Adjustment by another contextual characteristic such as socio-economic status, other pollutants, availability of health food 
 
Passive and Active smoking 
For validity of exposure, needed to report on how the data was collected (such as providing the questions on the survey) 
Adjustment by individual health behaviors or socio-economic status 
 
Scoring Approach 
1. All studies that meet final eligibility criteria will be reviewed and scored by 2 study personnel  
2. The 2 study personnel will the compare scores, discuss discrepancies, and attempt to come to a consensus for each score 
component 
3. If no consensus can be reach for the score component, a third reviewer will independently score the component, and the 




Disability adjusted life years (DALYs) are a function of the sum of years of life lost (YLL) and years living with disability (YLD)[2]. 
Years of living with disability are estimated by multiplying the prevalence of a disease by the loss of health associated with that 
disability associated with that disease (measured by the disability weight). In brief, the GBD constructs disability weights using 
survey-based methods. Surveys, that were conducted in several geographically diverse countries, provide respondents comparisons 
of different health states, where responders mark for each comparison which health state they consider more unhealthy. Analyses of 
these results based on the idea that comparisons of states that result in similar health loss would on average result in 50/50 ranking 
of what is higher than that other, while more disparate health states would result in a higher proportion of one being ranked higher 
than the other. This is analytically translated into a weight from 0 to 1 that represents the severity of health loss associated with the 
health condition[3]. For chronic kidney disease, weights are available by CKD stage, dialysis status, anemia status, and underlying 
cause (diabetes type 1, diabetes type 2, hypertension, glomerulonephritis, and other causes)[4]. These weights are not unique for 
each country. 
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Table S1:  Estimates of the incidence of CKD attributable to PM2.5 for 194 countries and territories. 
Geography PM2.5 PAF 
(95% UI) 
Incidence 
number (95% UI) 
Incidence rate 
(per 100,000) (95% 
UI) 
Age-standardized 
incidence rate (per 








44.5 (37.9-50.7) 49.7 (42.7-56.4) 
World Bank Low 




39.0 (33.5-44.2) 66.0 (56.8-74.8) 
World Bank Lower 




54.5 (46.9-61.8) 68.2 (58.8-77.3) 
World Bank Upper 




38.4 (32.4-44.1) 34.0 (28.9-38.8) 
World Bank High 




32.1 (26.4-37.5) 21.0 (17.6-24.1) 
Afghanistan 
56.9 
24.0 (22.2-25.8) 15,904.7 
(13,528.8-
18,180.5) 
48.4 (41.2-55.3) 97.0 (83.6-109.9) 
Albania 
18.2 
10.7 (9.6-11.7) 1,001.2 (824.9-
1,166.5) 
36.2 (29.8-42.2) 25.4 (21.4-29.3) 
Algeria 
38.9 
19.1 (17.5-20.7) 24,796.4 
(21,110.7-
28,291.0) 
61.3 (52.2-69.9) 68.5 (58.6-77.8) 
American Samoa 12.5 7.4 (6.6-8.1) 9.7 (8.2-11.2) 17.5 (14.8-20.1) 20.4 (17.5-23.3) 
Andorra 10.3 5.9 (5.3-6.5) 14.7 (12.3-17.1) 18.4 (15.3-21.4) 11.4 (9.5-13.3) 
Angola 
32.4 
16.8 (15.3-18.3) 9,007.2 (7,686.9-
10,267.2) 
31.9 (27.3-36.4) 59.9 (51.1-68.2) 
Antigua and Barbuda 18.6 10.9 (9.8-12.0) 32.6 (27.6-37.4) 36.6 (31.1-42.0) 32.4 (27.6-37.1) 
Argentina 
13.3 
7.9 (7.0-8.7) 9,803.7 (8,175.1-
11,358.1) 
22.1 (18.5-25.7) 18.7 (15.6-21.6) 
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16.9 (15.4-18.4) 2,021.0 (1,709.1-
2,314.9) 
66.8 (56.5-76.5) 51.8 (44.4-59.0) 
Australia 
8.6 
4.7 (4.2-5.2) 4,004.9 (3,292.5-
4,666.2) 
16.7 (13.8-19.5) 10.4 (8.6-12.1) 
Austria 
12.5 
7.4 (6.6-8.1) 2,741.0 (2,253.8-
3,200.5) 
31.2 (25.6-36.4) 16.0 (13.3-18.5) 
Azerbaijan 
19.9 
11.5 (10.4-12.7) 3,515.1 (2,914.4-
4,078.5) 
34.4 (28.5-39.9) 35.8 (30.3-41.1) 
Bahrain 
70.8 
26.7 (24.8-28.7) 1,314.9 (1,092.6-
1,520.2) 
89.4 (74.3-103.4) 96.0 (83.1-108.4) 
Bangladesh 
60.8 
24.8 (23.0-26.7) 92,827.9 
(79,740.5-
105,364.4) 
59.1 (50.8-67.1) 69.3 (59.2-78.9) 
Barbados 
23.1 
13.1 (11.8-14.3) 165.4 (138.4-
190.9) 
55.9 (46.8-64.5) 37.3 (31.6-42.7) 
Belarus 
18.8 
11.0 (9.9-12.1) 4,763.7 (3,967.8-
5,511.0) 
50.2 (41.8-58.1) 33.2 (28.0-38.1) 
Belgium 
12.9 
7.6 (6.8-8.4) 3,510.4 (2,896.0-
4,090.2) 
31.0 (25.6-36.1) 16.2 (13.4-18.9) 
Belize 
23 
13.0 (11.8-14.3) 117.5 (100.6-
133.8) 
29.7 (25.5-33.9) 39.8 (33.9-45.4) 
Benin 
39 
19.1 (17.5-20.7) 5,054.0 (4,373.0-
5,702.2) 
43.6 (37.7-49.2) 74.5 (64.3-84.3) 
Bermuda 11.6 6.8 (6.1-7.5) 20.7 (17.2-24.1) 31.4 (26.1-36.5) 18.5 (15.6-21.4) 
Bhutan 
37.9 
18.8 (17.2-20.3) 380.9 (327.0-
432.5) 
39.8 (34.2-45.2) 53.5 (45.6-61.0) 
Bolivia 
21.6 
12.4 (11.2-13.6) 3,241.6 (2,762.1-
3,706.5) 




15.0 (13.6-16.4) 2,036.2 (1,670.9-
2,383.3) 
59.9 (49.2-70.1) 36.7 (30.6-42.5) 
Botswana 
23.1 
13.1 (11.8-14.3) 767.6 (652.1-
877.7) 
33.6 (28.6-38.5) 46.4 (39.6-53.0) 
Brazil 
12.7 
7.5 (6.7-8.3) 45,722.2 
(38,549.1-
52,754.7) 
21.6 (18.2-24.9) 20.1 (17.0-23.2) 
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Brunei 5.9 2.7 (2.4-3.0) 18.5 (15.3-21.5) 4.3 (3.5-5.0) 5.7 (4.7-6.6) 
Bulgaria 
19.1 
11.1 (10.0-12.2) 3,510.1 (2,895.3-
4,086.1) 
49.8 (41.1-57.9) 27.0 (22.8-31.1) 
Burkina Faso 
42.9 
20.3 (18.7-22.0) 10,243.5 
(8,895.7-
11,531.2) 
48.5 (42.1-54.6) 81.8 (70.8-92.3) 
Burundi 
38.9 
19.1 (17.5-20.7) 3,674.0 (3,152.5-
4,171.2) 
33.7 (28.9-38.2) 63.0 (54.3-71.4) 
Cambodia 
25.6 
14.2 (12.8-15.5) 3,940.2 (3,327.0-
4,521.5) 
24.4 (20.6-28.0) 31.5 (26.6-36.1) 
Cameroon 
72.8 
27.1 (25.1-29.0) 17,176.5 
(14,927.0-
19,332.8) 
61.9 (53.8-69.6) 103.1 (89.7-115.9) 
Canada 
6.4 
3.1 (2.7-3.4) 4,294.0 (3,557.7-
4,996.5) 
11.9 (9.9-13.9) 6.7 (5.7-7.8) 
Cape Verde 
34.8 
17.7 (16.1-19.2) 315.5 (272.0-
356.8) 




24.0 (22.1-25.8) 2,429.9 (2,088.3-
2,759.2) 
52.6 (45.2-59.7) 85.7 (74.1-97.0) 
Chad 
66 
25.9 (24.0-27.8) 8,070.8 (7,018.7-
9,083.0) 
53.0 (46.1-59.7) 98.5 (85.6-110.8) 
Chile 
21 
12.1 (10.9-13.3) 6,568.9 (5,466.9-
7,602.8) 
36.7 (30.5-42.4) 29.0 (24.3-33.5) 
China 
52.7 
23.0 (21.2-24.7) 466,736.7 
(389,597.1-
539,690.2) 
33.0 (27.6-38.2) 25.9 (21.9-29.7) 
Colombia 
16.5 
9.8 (8.8-10.8) 17,797.4 
(14,987.7-
20,509.8) 
35.2 (29.6-40.5) 33.3 (28.1-38.3) 
Comoros 
20.5 
11.8 (10.7-13.0) 207.9 (177.2-
237.6) 
28.9 (24.7-33.1) 39.4 (33.5-45.1) 
Congo 
46.6 
21.4 (19.7-23.1) 2,477.6 (2,129.1-
2,812.0) 
50.4 (43.3-57.2) 76.4 (65.9-86.4) 
Costa Rica 
15.7 
9.3 (8.4-10.3) 1,658.0 (1,405.7-
1,905.5) 
35.6 (30.2-40.9) 33.6 (28.6-38.6) 
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14.3 (12.9-15.6) 8,551.6 (7,290.4-
9,743.4) 
34.3 (29.2-39.0) 55.8 (47.8-63.4) 
Croatia 
17.9 
10.5 (9.5-11.6) 1,947.5 (1,597.0-
2,276.3) 
45.6 (37.4-53.2) 25.0 (21.0-28.8) 
Cuba 
19.7 
11.4 (10.3-12.6) 5,230.4 (4,328.6-
6,077.4) 
46.0 (38.0-53.4) 30.5 (25.6-35.2) 
Cyprus 
17.3 
10.2 (9.2-11.2) 418.4 (345.2-
487.0) 
33.1 (27.3-38.6) 22.4 (18.7-25.9) 
Czech Republic 
16.1 
9.5 (8.6-10.5) 4,063.9 (3,343.8-
4,741.7) 
38.4 (31.6-44.8) 21.9 (18.3-25.2) 
Democratic Republic 
of the Congo 44.9 
20.9 (19.2-22.6) 33,577.0 
(28,826.9-
38,119.3) 
41.5 (35.6-47.1) 73.3 (63.0-83.2) 
Denmark 
10 
5.7 (5.1-6.3) 1,298.3 (1,054.1-
1,525.9) 
22.6 (18.4-26.6) 11.9 (9.8-13.8) 
Djibouti 
45.5 
21.1 (19.4-22.8) 510.3 (435.7-
581.9) 
45.8 (39.1-52.3) 69.2 (59.7-78.4) 
Dominica 19.5 11.3 (10.2-12.5) 30.6 (26.0-35.2) 44.4 (37.7-51.0) 35.7 (30.4-40.9) 
Dominican Republic 
13.7 
8.1 (7.3-9.0) 2,268.3 (1,918.4-
2,612.9) 
21.7 (18.4-25.0) 23.9 (20.2-27.5) 
Ecuador 
14.9 
8.8 (7.9-9.8) 3,957.1 (3,366.8-
4,542.9) 
23.7 (20.2-27.2) 26.1 (22.2-30.0) 
Egypt 
87 
29.2 (27.1-31.2) 82,259.9 
(70,288.5-
93,515.0) 
85.3 (72.8-96.9) 113.5 (98.3-127.9) 
El Salvador 
24.5 
13.7 (12.4-15.0) 2,928.0 (2,512.4-
3,329.8) 
48.1 (41.3-54.7) 51.3 (43.8-58.4) 
Equatorial Guinea 
53.2 
23.1 (21.3-24.9) 567.8 (491.2-
641.7) 
42.2 (36.5-47.7) 83.5 (72.2-94.4) 
Eritrea 
48 
21.8 (20.0-23.5) 2,359.8 (2,036.0-
2,668.9) 
40.3 (34.7-45.5) 74.1 (63.8-84.0) 
Estonia 
6.7 
3.3 (2.9-3.6) 233.1 (195.8-
269.7) 
17.7 (14.9-20.5) 10.5 (9.0-12.1) 
Ethiopia 
39 
19.1 (17.5-20.7) 33,061.2 
(28,581.7-
37,326.7) 
32.1 (27.8-36.3) 61.1 (52.7-69.1) 
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Federated States of 
Micronesia 
11.3 
6.6 (5.9-7.3) 14.1 (12.0-16.2) 13.6 (11.6-15.6) 17.7 (15.1-20.3) 
Fiji 
10.8 
6.2 (5.6-6.9) 123.9 (104.7-
143.0) 
13.7 (11.5-15.8) 15.7 (13.4-18.1) 
Finland 
5.9 
2.7 (2.4-3.0) 597.8 (489.0-
698.9) 
10.8 (8.9-12.7) 5.2 (4.3-6.0) 
France 
11.8 
6.9 (6.2-7.6) 17,902.9 
(14,832.8-
20,809.6) 
27.2 (22.6-31.7) 14.0 (11.7-16.2) 
Gabon 
44.4 
20.8 (19.1-22.4) 916.4 (789.9-
1,036.7) 
53.8 (46.4-60.9) 74.0 (64.1-83.6) 
Georgia 
22.2 
12.6 (11.4-13.9) 2,104.9 (1,763.9-
2,426.5) 
57.0 (47.8-65.7) 39.3 (33.4-45.0) 
Germany 
12 
7.0 (6.3-7.8) 27,970.8 
(22,949.4-
32,700.7) 
33.6 (27.6-39.3) 15.5 (12.9-18.0) 
Ghana 
34.7 
17.7 (16.1-19.2) 13,942.4 
(12,002.1-
15,787.6) 
46.2 (39.7-52.3) 67.1 (57.8-75.8) 
Greece 
16.2 
9.6 (8.6-10.6) 4,720.5 (3,874.2-
5,516.5) 
45.4 (37.2-53.0) 20.8 (17.3-24.0) 
Greenland 11.6 6.8 (6.1-7.5) 10.3 (8.4-12.0) 18.3 (15.0-21.3) 15.9 (13.2-18.4) 
Grenada 22.7 12.9 (11.6-14.1) 55.7 (47.1-63.9) 50.2 (42.4-57.6) 40.0 (34.0-45.7) 
Guam 11.6 6.8 (6.1-7.5) 28.7 (24.1-33.1) 17.1 (14.3-19.7) 16.2 (13.7-18.6) 
Guatemala 
24.1 
13.5 (12.2-14.8) 6,113.9 (5,246.7-
6,954.1) 
36.1 (31.0-41.1) 50.9 (43.4-58.0) 
Guinea 
26.1 
14.4 (13.0-15.7) 4,150.5 (3,574.1-
4,710.2) 
35.1 (30.2-39.8) 56.9 (48.9-64.6) 
Guinea-Bissau 
29.8 
15.9 (14.4-17.3) 701.1 (602.6-
794.4) 
37.8 (32.5-42.8) 65.3 (56.1-73.9) 
Guyana 
22.4 
12.7 (11.5-14.0) 256.7 (217.3-
294.3) 
34.6 (29.3-39.7) 39.2 (33.4-44.7) 
Haiti 
15 
8.9 (8.0-9.8) 2,137.7 (1,811.4-
2,458.6) 
18.1 (15.3-20.8) 26.9 (22.8-31.0) 
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11.9 (10.7-13.1) 2,711.0 (2,306.7-
3,102.4) 
28.5 (24.3-32.7) 40.5 (34.4-46.4) 
Hungary 
15.9 
9.4 (8.5-10.4) 3,890.2 (3,206.3-
4,532.5) 
40.0 (33.0-46.6) 22.6 (19.0-26.0) 
Iceland 6.5 3.1 (2.8-3.5) 31.3 (25.9-36.4) 9.3 (7.7-10.8) 6.1 (5.1-7.1) 
India 
90.9 
29.6 (27.6-31.7) 918,970.3 
(793,181.3-
1,037,738.3) 
66.6 (57.5-75.2) 77.7 (67.0-87.9) 
Indonesia 
16.5 
9.8 (8.8-10.8) 50,764.4 
(42,827.6-
58,458.3) 
19.7 (16.6-22.6) 22.2 (18.8-25.5) 
Iran 
39 
19.1 (17.5-20.7) 60,260.1 
(51,573.3-
68,525.9) 
73.3 (62.8-83.4) 77.0 (66.5-87.1) 
Iraq 
61.6 
25.0 (23.1-26.9) 27,713.8 
(23,935.2-
31,352.9) 
64.0 (55.3-72.4) 95.5 (82.5-108.0) 
Ireland 
8.2 
4.4 (3.9-4.9) 660.7 (551.2-
766.3) 
13.6 (11.3-15.8) 9.3 (7.8-10.8) 
Israel 
21.4 
12.3 (11.1-13.5) 3,104.6 (2,586.0-
3,591.3) 
34.7 (28.9-40.1) 28.3 (23.5-32.7) 
Italy 
16.8 
9.9 (8.9-10.9) 25,768.4 
(21,046.3-
30,195.0) 
42.5 (34.7-49.8) 18.4 (15.2-21.4) 
Jamaica 
13.4 
7.9 (7.1-8.8) 685.9 (584.1-
787.6) 
24.7 (21.0-28.3) 24.0 (20.4-27.6) 
Japan 
11.7 
6.8 (6.1-7.6) 41,738.0 
(34,116.5-
48,893.9) 
32.5 (26.6-38.1) 13.5 (11.3-15.7) 
Jordan 
33 
17.1 (15.5-18.6) 4,876.2 (4,151.5-
5,566.5) 
45.8 (39.0-52.3) 64.6 (55.5-73.3) 
Kazakhstan 
13.8 
8.2 (7.3-9.0) 4,246.2 (3,566.9-
4,904.8) 
23.7 (19.9-27.4) 24.3 (20.5-28.0) 
Kenya 
28.6 
15.4 (14.0-16.8) 14,336.6 
(12,288.4-
16,269.5) 
29.7 (25.4-33.7) 51.1 (43.9-58.0) 
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Kiribati 10.6 6.1 (5.5-6.7) 12.4 (10.5-14.3) 10.5 (8.9-12.1) 15.2 (12.9-17.4) 
Kuwait 
60.7 
24.8 (23.0-26.7) 3,051.4 (2,524.1-
3,541.6) 
71.6 (59.2-83.1) 85.8 (73.5-97.5) 
Kyrgyzstan 
22.7 
12.9 (11.6-14.1) 1,838.1 (1,551.7-
2,110.2) 
28.9 (24.4-33.1) 37.0 (31.2-42.4) 
Laos 
25.1 
13.9 (12.6-15.3) 1,629.1 (1,388.8-
1,856.5) 
23.4 (19.9-26.6) 32.8 (27.9-37.5) 
Latvia 
13.4 
7.9 (7.1-8.8) 839.8 (699.0-
973.2) 
43.2 (35.9-50.0) 25.0 (21.1-28.8) 
Lebanon 
30.6 
16.2 (14.7-17.6) 4,015.9 (3,426.0-
4,579.2) 
47.2 (40.2-53.8) 59.6 (50.9-68.0) 
Lesotho 
28 
15.2 (13.7-16.5) 804.6 (690.2-
913.0) 
41.3 (35.4-46.9) 57.6 (49.4-65.4) 
Liberia 
18 
10.6 (9.5-11.6) 1,212.9 (1,035.6-
1,387.4) 
25.7 (21.9-29.4) 41.6 (35.6-47.5) 
Libya 
54.3 
23.4 (21.6-25.2) 5,353.5 (4,570.3-
6,105.9) 
77.5 (66.2-88.4) 93.8 (80.9-106.2) 
Lithuania 
11.9 
7.0 (6.2-7.7) 1,047.8 (878.1-
1,212.2) 
36.8 (30.8-42.6) 21.6 (18.3-24.9) 
Luxembourg 
10.4 
6.0 (5.3-6.6) 118.4 (97.9-
137.8) 
20.0 (16.6-23.3) 12.8 (10.6-14.9) 
Macedonia 
29.7 
15.8 (14.4-17.3) 1,221.3 (1,019.9-
1,412.4) 
56.2 (46.9-64.9) 38.5 (32.5-44.1) 
Madagascar 
22.5 
12.8 (11.5-14.0) 6,055.4 (5,123.5-
6,943.5) 
23.2 (19.6-26.6) 41.8 (35.7-47.8) 
Malawi 
23.6 
13.3 (12.0-14.5) 4,504.2 (3,864.1-
5,124.4) 
26.2 (22.5-29.8) 46.1 (39.4-52.5) 
Malaysia 
16 
9.5 (8.5-10.4) 6,085.8 (5,114.9-
7,019.8) 
19.9 (16.7-22.9) 22.4 (18.9-25.8) 
Maldives 7.8 4.1 (3.7-4.5) 31.1 (26.1-35.9) 6.8 (5.7-7.8) 9.4 (7.9-10.8) 
Mali 
38.5 
19.0 (17.3-20.5) 8,382.3 (7,251.2-
9,458.2) 
41.4 (35.8-46.7) 71.3 (61.6-80.6) 
Malta 
13.9 
8.2 (7.4-9.1) 155.5 (127.4-
181.9) 
35.8 (29.3-41.9) 18.2 (15.2-21.0) 
Marshall Islands 10.2 5.8 (5.2-6.4) 6.2 (5.3-7.2) 11.1 (9.4-12.7) 15.6 (13.3-17.9) 
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21.6 (19.9-23.3) 2,161.8 (1,872.8-
2,438.3) 
55.2 (47.8-62.3) 83.6 (72.3-94.4) 
Mauritius 
14.5 
8.6 (7.7-9.5) 390.6 (328.9-
450.5) 
30.7 (25.9-35.4) 24.3 (20.8-27.8) 
Mexico 
20.9 
12.0 (10.8-13.2) 56,909.4 
(49,114.2-
64,734.9) 
45.0 (38.8-51.1) 47.4 (40.9-54.0) 
Moldova 
16.3 
9.6 (8.7-10.6) 1,447.7 (1,207.9-
1,672.5) 
38.9 (32.5-44.9) 27.4 (23.1-31.6) 
Mongolia 
40.1 
19.5 (17.8-21.1) 1,575.7 (1,333.1-
1,807.6) 
48.5 (41.0-55.6) 61.3 (52.3-69.8) 
Montenegro 
20.8 
12.0 (10.8-13.2) 278.1 (229.5-
324.0) 
44.4 (36.6-51.7) 29.8 (25.0-34.4) 
Morocco 
32.6 
16.9 (15.4-18.4) 20,288.7 
(17,297.5-
23,141.3) 
57.2 (48.7-65.2) 59.9 (51.2-68.1) 
Mozambique 
21.3 
12.2 (11.0-13.4) 6,727.8 (5,743.6-
7,678.4) 
22.4 (19.1-25.6) 42.3 (36.2-48.3) 
Myanmar 
35.6 
18.0 (16.4-19.5) 20,984.6 
(17,842.2-
23,961.8) 
39.7 (33.8-45.4) 44.1 (37.6-50.2) 
Namibia 
25.4 
14.1 (12.7-15.4) 812.2 (691.8-
926.2) 
34.5 (29.4-39.4) 49.4 (42.1-56.3) 
Nepal 
99.7 
30.6 (28.5-32.7) 23,777.4 
(20,613.7-
26,776.7) 
79.5 (69.0-89.6) 97.9 (84.5-110.5) 
Netherlands 
12 
7.0 (6.3-7.8) 4,621.9 (3,781.5-
5,411.7) 
27.1 (22.2-31.8) 14.3 (11.9-16.6) 
New Zealand 
6 
2.8 (2.5-3.0) 445.3 (370.5-
517.8) 
10.0 (8.3-11.6) 6.2 (5.2-7.2) 
Nicaragua 
17.6 
10.4 (9.3-11.4) 2,028.4 (1,735.9-
2,318.7) 
31.7 (27.1-36.2) 40.7 (34.8-46.5) 
Niger 
94.1 
30.0 (28.0-32.1) 12,803.7 
(11,154.7-
14,371.2) 
59.9 (52.2-67.2) 113.9 (98.8-128.2) 
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26.9 (25.0-28.9) 136,688.1 
(117,912.4-
154,581.2) 
66.3 (57.2-75.0) 109.8 (95.5-123.4) 
North Korea 
32 
16.7 (15.2-18.2) 7,541.1 (6,311.9-
8,709.2) 




5.6 (5.0-6.2) 7.2 (5.9-8.3) 15.9 (13.2-18.6) 13.8 (11.8-15.8) 
Norway 
7 
3.5 (3.1-3.9) 584.3 (483.2-
679.9) 
11.1 (9.2-12.9) 6.4 (5.3-7.5) 
Oman 
41.1 
19.8 (18.1-21.4) 2,138.3 (1,783.8-
2,478.5) 
47.1 (39.3-54.6) 72.0 (61.9-81.7) 
Pakistan 
58.3 
24.3 (22.5-26.1) 100,360.5 
(87,112.4-
113,120.3) 
46.8 (40.7-52.8) 70.6 (60.9-80.0) 
Palestine 
33.2 
17.1 (15.6-18.6) 2,045.4 (1,744.5-
2,332.3) 
42.2 (36.0-48.1) 65.8 (56.6-74.7) 
Panama 
11.4 
6.6 (5.9-7.3) 887.4 (749.8-
1,024.0) 
22.6 (19.1-26.1) 22.4 (19.0-25.9) 
Papua New Guinea 
12.3 
7.2 (6.5-8.0) 1,018.0 (865.7-
1,170.2) 
11.0 (9.4-12.7) 17.5 (14.8-20.1) 
Paraguay 
11.9 
7.0 (6.2-7.7) 1,198.8 (1,012.2-
1,383.5) 
17.3 (14.6-20.0) 21.2 (17.9-24.5) 
Peru 
24.8 
13.8 (12.5-15.1) 11,369.3 
(9,656.1-
12,993.2) 
34.2 (29.1-39.1) 36.7 (31.1-42.0) 
Philippines 
18.1 
10.6 (9.6-11.7) 23,459.4 
(20,052.9-
26,817.4) 
22.7 (19.4-25.9) 28.6 (24.5-32.7) 
Poland 
20.9 
12.0 (10.8-13.2) 15,608.5 
(12,575.5-
18,474.4) 
40.7 (32.8-48.1) 25.1 (20.5-29.5) 
Portugal 
8.2 
4.4 (3.9-4.9) 2,147.7 (1,771.6-
2,500.0) 
20.1 (16.6-23.4) 9.4 (7.8-10.9) 
Puerto Rico 
8.3 
4.5 (4.0-4.9) 791.1 (657.6-
919.0) 
21.6 (17.9-25.1) 13.0 (11.0-15.0) 
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29.7 (27.6-31.7) 1,883.1 (1,535.2-
2,226.5) 
68.5 (55.9-81.0) 102.5 (88.5-115.8) 
Romania 
14.6 
8.7 (7.8-9.6) 6,673.5 (5,482.6-
7,796.8) 
34.3 (28.2-40.1) 20.0 (16.6-23.1) 
Russian Federation 
16.2 
9.6 (8.6-10.6) 74,014.8 
(62,393.5-
85,277.5) 
50.6 (42.7-58.3) 35.0 (29.8-40.2) 
Rwanda 
43.2 
20.4 (18.7-22.1) 5,068.9 (4,338.0-
5,766.9) 
40.4 (34.6-45.9) 68.2 (58.7-77.2) 
Saint Lucia 22.4 12.7 (11.5-14.0) 78.5 (66.5-89.8) 44.5 (37.7-50.9) 38.4 (32.7-43.9) 
Saint Vincent and the 
Grenadines 
22.2 
12.6 (11.4-13.9) 50.1 (42.4-57.4) 43.9 (37.2-50.3) 37.9 (32.2-43.3) 
Samoa 11.5 6.7 (6.0-7.4) 25.5 (21.8-29.3) 12.8 (11.0-14.7) 16.8 (14.3-19.2) 
Sao Tome and 
Principe 
28.5 
15.4 (13.9-16.7) 91.6 (78.6-103.9) 45.7 (39.2-51.9) 65.7 (56.8-74.4) 
Saudi Arabia 
87.9 
29.3 (27.2-31.3) 28,163.2 
(23,683.8-
32,295.5) 
81.8 (68.8-93.8) 109.6 (94.7-123.7) 
Senegal 
40.7 
19.7 (18.0-21.3) 7,018.5 (6,065.1-
7,928.8) 
47.8 (41.3-54.0) 73.9 (63.9-83.5) 
Serbia 
24.7 
13.8 (12.5-15.1) 5,089.3 (4,230.2-
5,901.4) 
57.4 (47.7-66.5) 34.9 (29.4-40.1) 
Seychelles 20.2 11.7 (10.5-12.8) 32.5 (27.6-37.2) 32.2 (27.3-36.9) 30.3 (25.8-34.7) 
Sierra Leone 
21.6 
12.4 (11.2-13.6) 2,367.4 (2,030.5-
2,695.7) 
30.2 (25.9-34.4) 48.7 (41.8-55.4) 
Singapore 
19.1 
11.1 (10.0-12.2) 1,424.7 (1,180.7-
1,653.4) 
25.6 (21.2-29.7) 21.1 (17.6-24.4) 
Slovakia 
17.6 
10.4 (9.3-11.4) 2,080.5 (1,720.5-
2,417.1) 
38.4 (31.7-44.6) 24.7 (20.7-28.4) 
Slovenia 
16 
9.5 (8.5-10.4) 809.9 (673.0-
937.6) 
39.1 (32.5-45.3) 21.8 (18.3-25.2) 
Solomon Islands 11.9 7.0 (6.2-7.7) 71.9 (61.3-82.6) 11.3 (9.6-13.0) 17.0 (14.4-19.5) 
Somalia 
32 
16.7 (15.2-18.2) 5,113.5 (4,392.8-
5,796.7) 
30.3 (26.0-34.3) 57.3 (49.3-64.9) 
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13.9 (12.6-15.3) 23,615.7 
(20,093.0-
26,951.6) 
43.0 (36.6-49.0) 49.4 (42.1-56.3) 
South Korea 
25 
13.9 (12.6-15.2) 18,219.4 
(15,123.7-
21,144.5) 
34.6 (28.7-40.1) 22.2 (18.7-25.6) 
South Sudan 
45.6 
21.1 (19.4-22.8) 3,798.8 (3,267.8-
4,305.4) 
38.2 (32.9-43.3) 70.7 (61.1-79.9) 
Spain 
9.7 
5.5 (4.9-6.1) 9,838.9 (8,058.4-
11,501.4) 
21.2 (17.4-24.8) 10.6 (8.8-12.4) 
Sri Lanka 
11.1 
6.4 (5.8-7.1) 3,705.4 (3,099.6-
4,290.5) 
17.2 (14.4-19.9) 15.2 (12.8-17.5) 
Sudan 
55.4 
23.6 (21.8-25.4) 21,369.4 
(18,342.8-
24,284.5) 
53.1 (45.6-60.3) 89.2 (77.1-100.9) 
Suriname 
24.8 
13.8 (12.5-15.1) 256.0 (217.5-
292.6) 
44.7 (38.0-51.1) 43.4 (37.1-49.4) 
Swaziland 
17.2 
10.1 (9.1-11.2) 275.8 (236.3-
315.2) 
24.5 (21.0-28.0) 38.8 (33.2-44.4) 
Sweden 
6.2 
2.9 (2.6-3.2) 1,046.7 (844.4-
1,235.3) 
10.4 (8.4-12.3) 5.2 (4.2-6.0) 
Switzerland 
10.3 
5.9 (5.3-6.5) 2,010.3 (1,676.0-
2,330.9) 
23.4 (19.5-27.1) 12.3 (10.3-14.3) 
Syria 
43.8 
20.6 (18.9-22.3) 11,597.0 
(9,886.4-
13,232.9) 
64.0 (54.5-73.0) 76.9 (66.0-87.3) 
Tajikistan 
46.2 
21.3 (19.6-23.0) 3,912.0 (3,351.9-
4,449.7) 
42.3 (36.3-48.1) 62.7 (53.6-71.5) 
Tanzania 
29.1 
15.6 (14.2-17.0) 16,114.8 
(13,784.6-
18,318.9) 
29.9 (25.5-33.9) 51.1 (43.5-58.3) 
Thailand 
26.3 
14.5 (13.1-15.8) 31,623.1 
(26,430.2-
36,498.1) 
44.8 (37.4-51.7) 33.9 (28.7-38.8) 
The Bahamas 
17.4 
10.3 (9.2-11.3) 118.7 (99.4-
137.0) 
31.6 (26.5-36.5) 30.8 (26.0-35.4) 
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17.4 (15.9-18.9) 889.7 (768.8-
1,004.5) 
41.7 (36.1-47.1) 68.6 (59.2-77.4) 
Timor-Leste 
19.3 
11.2 (10.1-12.4) 242.2 (204.4-
278.4) 
18.8 (15.9-21.6) 26.0 (22.1-29.9) 
Togo 
35.7 
18.0 (16.4-19.6) 3,475.2 (2,985.4-
3,943.1) 
46.2 (39.7-52.5) 71.0 (61.3-80.1) 
Tonga 10.8 6.2 (5.6-6.9) 14.0 (12.0-16.0) 13.6 (11.6-15.6) 16.2 (13.8-18.6) 
Trinidad and Tobago 
24.1 
13.5 (12.2-14.8) 712.1 (598.4-
819.8) 
51.2 (43.0-58.9) 40.8 (34.6-46.7) 
Tunisia 
37.7 
18.7 (17.1-20.3) 8,602.1 (7,307.6-
9,827.0) 
75.2 (63.9-85.9) 68.8 (59.0-78.1) 
Turkey 
44.3 
20.7 (19.1-22.4) 70,831.1 
(60,736.6-
80,488.7) 
88.0 (75.5-100.0) 80.3 (69.3-90.8) 
Turkmenistan 
21.8 
12.5 (11.2-13.7) 1,657.0 (1,401.8-
1,900.8) 
33.3 (28.2-38.2) 39.3 (33.4-44.9) 
Uganda 
50.5 
22.4 (20.7-24.2) 14,411.2 
(12,439.8-
16,306.1) 
36.9 (31.8-41.7) 73.7 (63.6-83.4) 
Ukraine 
20.3 
11.7 (10.6-12.9) 25,093.9 
(20,974.7-
28,973.2) 
56.2 (46.9-64.8) 35.9 (30.5-41.2) 
United Arab Emirates 
40.9 
19.7 (18.1-21.4) 5,711.1 (4,541.6-
6,838.4) 
58.7 (46.7-70.3) 71.4 (61.2-81.2) 
United Kingdom 
10.5 
6.0 (5.4-6.7) 14,772.9 
(12,198.3-
17,196.8) 
22.2 (18.3-25.8) 12.3 (10.2-14.3) 
United States 
7.4 
3.8 (3.4-4.2) 56,745.2 
(47,166.4-
65,967.0) 
17.5 (14.5-20.3) 11.0 (9.3-12.8) 
Uruguay 
9.3 
5.2 (4.6-5.7) 629.2 (522.9-
730.7) 
18.4 (15.3-21.4) 12.2 (10.2-14.2) 
Uzbekistan 
28.5 
15.4 (13.9-16.7) 12,307.5 
(10,433.5-
14,090.2) 
38.2 (32.4-43.7) 48.2 (41.3-54.8) 
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Vanuatu 11.7 6.8 (6.1-7.6) 34.2 (29.2-39.3) 11.9 (10.2-13.7) 17.1 (14.5-19.6) 
Venezuela 
17 
10.0 (9.0-11.0) 10,450.8 
(8,815.8-
12,032.2) 
33.9 (28.6-39.0) 35.6 (30.1-41.0) 
Vietnam 
29.6 
15.8 (14.3-17.2) 33,138.2 
(28,080.6-
37,947.6) 
34.5 (29.2-39.5) 35.8 (30.5-40.8) 
Virgin Islands, U.S. 10.3 5.9 (5.3-6.5) 30.6 (25.1-35.7) 29.1 (23.9-34.0) 17.8 (15.0-20.5) 
Yemen 
50.5 
22.4 (20.7-24.2) 14,314.3 
(12,310.9-
16,249.8) 
47.0 (40.4-53.4) 82.7 (71.4-93.5) 
Zambia 
27.4 
14.9 (13.5-16.3) 4,553.7 (3,887.9-
5,182.4) 
26.2 (22.4-29.8) 49.9 (42.6-56.9) 
Zimbabwe 
22.3 
12.7 (11.5-13.9) 4,054.3 (3,458.6-
4,631.3) 
27.6 (23.5-31.5) 46.2 (39.3-52.9) 
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Table S2:  Estimates of the prevalence of CKD attributable to PM2.5 for 194 countries and territories. 
Geography Prevalence number (95% UI) Prevalence rate 
(per 100,000) (95% 
UI) 
Age-standardized 
prevalence rate (per 












































American Samoa 465.9 (404.0-526.9) 837.4 (726.2-947.1) 973.1 (846.7-1,097.1) 











682.9 (596.6-768.0) 594.0 (518.8-668.2) 





483.7 (418.6-546.8) 327.1 (283.7-369.1) 
Austria 63,105.3 (54,625.3-71,547.7) 717.7 (621.2-813.7) 409.1 (355.7-461.5) 
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Belgium 83,948.0 (72,618.4-95,278.8) 741.6 (641.5-841.7) 429.8 (373.8-484.7) 








Bermuda 597.7 (517.6-676.6) 907.1 (785.6-
1,026.9) 
560.7 (487.6-632.4) 
Bhutan 12,996.0 (11,496.8-14,482.8) 1,357.4 (1,200.8-
1,512.7) 
1,697.6 (1,504.1-1,890.0) 
Bolivia 88,292.6 (77,226.2-99,152.8) 764.9 (669.0-859.0) 947.6 (828.4-1,064.7) 
Bosnia and Herzegovina 64,218.1 (56,332.3-72,272.3) 1,889.2 (1,657.2-
2,126.1) 
1,243.6 (1,091.4-1,395.6) 





593.3 (515.9-669.2) 549.6 (478.0-619.8) 
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295.2 (255.7-334.0) 184.5 (160.2-208.1) 
Cape Verde 9,886.0 (8,693.8-11,068.7) 1,811.3 (1,592.8-
2,027.9) 
2,083.1 (1,834.3-2,330.3) 























Comoros 6,084.5 (5,307.8-6,852.5) 847.1 (738.9-954.0) 1,172.1 (1,022.4-1,320.0) 
Congo 74,371.8 (65,743.5-82,812.3) 1,513.8 (1,338.1-
1,685.5) 
2,339.5 (2,071.8-2,600.2) 
Costa Rica 47,043.8 (40,952.8-53,089.5) 1,010.9 (880.0-
1,140.8) 
946.8 (824.6-1,067.1) 













Cyprus 10,986.8 (9,584.4-12,368.6) 870.1 (759.1-979.6) 622.8 (543.6-700.2) 












Denmark 31,415.1 (27,122.3-35,682.2) 548.0 (473.2-622.5) 330.4 (286.4-373.2) 
Djibouti 15,517.8 (13,681.6-17,321.5) 1,394.1 (1,229.1-
1,556.1) 
2,076.6 (1,834.9-2,313.4) 
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Dominica 947.1 (828.2-1,064.4) 1,374.0 (1,201.4-
1,544.1) 
1,108.7 (968.9-1,246.3) 
Dominican Republic 66,099.5 (57,488.6-74,557.3) 632.4 (550.0-713.3) 681.5 (592.3-769.5) 
Ecuador 106,800.6 (93,056.7-
120,255.2) 






El Salvador 84,667.8 (74,192.0-94,942.5) 1,391.0 (1,218.9-
1,559.8) 
1,457.4 (1,275.4-1,636.5) 
Equatorial Guinea 17,297.2 (15,325.8-19,208.0) 1,286.0 (1,139.4-
1,428.1) 
2,582.4 (2,288.0-2,867.8) 
Eritrea 66,257.6 (58,595.3-73,739.9) 1,130.8 (1,000.0-
1,258.5) 
2,148.7 (1,901.9-2,388.8) 






Federated States of 
Micronesia 
712.4 (616.5-807.3) 685.5 (593.2-776.8) 853.8 (741.8-963.5) 
Fiji 7,457.8 (6,447.9-8,458.2) 822.3 (710.9-932.6) 897.7 (778.1-1,014.0) 
Finland 15,149.0 (13,113.3-17,154.0) 274.5 (237.6-310.9) 154.9 (134.6-174.5) 
France 419,724.0 (362,318.6-
477,342.8) 
638.7 (551.4-726.4) 362.0 (313.6-409.7) 
Gabon 28,672.2 (25,379.9-31,880.7) 1,683.9 (1,490.5-
1,872.3) 
2,333.1 (2,064.0-2,595.3) 
















Greenland 268.6 (232.4-304.4) 478.2 (413.9-542.0) 425.5 (369.1-480.6) 
Grenada 1,767.7 (1,550.1-1,980.8) 1,594.3 (1,398.0-
1,786.4) 
1,257.9 (1,102.5-1,410.1) 
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Guinea-Bissau 18,422.8 (16,187.8-20,692.0) 992.9 (872.4-
1,115.1) 
1,901.9 (1,673.3-2,132.4) 
Guyana 8,052.8 (7,044.9-9,040.7) 1,084.8 (949.1-
1,217.9) 
1,234.3 (1,079.7-1,385.9) 
Haiti 64,804.8 (56,401.3-73,081.6) 548.0 (477.0-618.0) 792.5 (689.8-893.8) 



























Ireland 17,337.7 (15,001.9-19,613.1) 356.7 (308.6-403.5) 263.0 (227.6-297.5) 





















810.6 (704.6-915.4) 825.6 (718.3-930.9) 
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854.5 (751.0-958.2) 1,499.9 (1,318.2-1,681.5) 
Kiribati 700.9 (605.8-795.1) 592.8 (512.4-672.5) 810.0 (702.7-914.7) 
Kuwait 84,266.8 (74,382.4-93,715.1) 1,977.1 (1,745.2-
2,198.7) 
2,411.1 (2,130.9-2,678.4) 
Kyrgyzstan 62,115.7 (54,321.8-69,759.3) 975.3 (853.0-
1,095.4) 
1,221.1 (1,069.2-1,370.0) 
Laos 79,957.8 (69,878.5-89,933.5) 1,147.1 (1,002.5-
1,290.3) 
1,503.3 (1,317.9-1,685.1) 








Lesotho 25,247.7 (22,169.1-28,318.2) 1,296.4 (1,138.3-
1,454.0) 
1,816.0 (1,594.6-2,036.1) 






Lithuania 37,226.2 (32,259.8-42,108.0) 1,307.3 (1,132.9-
1,478.7) 
789.7 (684.6-892.6) 
Luxembourg 3,135.9 (2,710.5-3,556.2) 531.0 (459.0-602.2) 358.2 (309.6-406.4) 





653.2 (569.4-736.2) 1,231.5 (1,075.1-1,386.8) 
Malawi 130,579.8 (114,143.4-
146,817.9) 












Malta 3,724.9 (3,228.9-4,219.5) 857.3 (743.2-971.2) 498.9 (433.8-563.0) 
Marshall Islands 308.2 (266.3-349.8) 547.4 (472.8-621.3) 716.6 (621.2-809.3) 
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Mauritania 58,659.6 (51,854.3-65,316.7) 1,498.7 (1,324.9-
1,668.8) 
2,437.8 (2,152.5-2,717.9) 








Moldova 56,639.1 (49,253.4-63,974.4) 1,521.8 (1,323.4-
1,718.9) 
1,095.4 (953.7-1,235.8) 
Mongolia 52,424.9 (46,222.9-58,535.1) 1,612.4 (1,421.6-
1,800.3) 
1,956.2 (1,733.5-2,176.6) 


























708.5 (613.8-801.8) 432.3 (374.8-488.7) 
New Zealand 12,379.8 (10,743.6-13,971.4) 278.3 (241.5-314.1) 189.5 (164.5-213.9) 


















Northern Mariana Islands 357.9 (308.5-407.6) 797.6 (687.5-908.2) 689.3 (598.0-778.3) 
Norway 16,269.3 (14,115.5-18,359.3) 309.1 (268.2-348.8) 202.4 (175.8-228.3) 
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Palestine 52,656.1 (46,241.6-59,036.8) 1,085.2 (953.0-
1,216.7) 
1,786.1 (1,563.7-2,008.2) 
Panama 26,308.6 (22,841.1-29,702.5) 671.0 (582.5-757.5) 662.6 (575.3-748.0) 
Papua New Guinea 53,891.3 (46,557.6-61,240.7) 584.0 (504.6-663.7) 863.3 (751.3-973.4) 
















Portugal 51,359.1 (44,406.7-58,189.5) 480.8 (415.7-544.8) 255.6 (221.6-288.5) 
Puerto Rico 24,319.4 (21,061.2-27,487.4) 663.4 (574.5-749.8) 418.9 (363.4-472.5) 


















Saint Lucia 2,423.5 (2,124.0-2,716.9) 1,373.3 (1,203.6-
1,539.6) 
1,183.8 (1,038.2-1,326.5) 
Saint Vincent and the 
Grenadines 
1,626.8 (1,424.3-1,825.4) 1,425.6 (1,248.2-
1,599.6) 
1,236.2 (1,083.1-1,386.3) 
Samoa 1,276.3 (1,108.5-1,440.6) 641.6 (557.2-724.2) 835.3 (726.1-942.3) 
Sao Tome and Principe 2,415.7 (2,122.6-2,712.2) 1,206.6 (1,060.2-
1,354.7) 
1,871.2 (1,644.1-2,100.8) 
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Seychelles 1,444.3 (1,262.5-1,623.2) 1,431.4 (1,251.1-
1,608.6) 
1,297.1 (1,136.3-1,454.2) 
Sierra Leone 63,107.2 (55,099.2-71,023.6) 806.0 (703.7-907.1) 1,411.2 (1,231.4-1,590.1) 
Singapore 72,021.0 (62,753.1-81,216.4) 1,293.4 (1,126.9-
1,458.5) 
1,039.8 (907.4-1,170.5) 
Slovakia 64,538.2 (56,158.8-72,891.1) 1,190.9 (1,036.3-
1,345.1) 
801.3 (699.2-901.9) 
Slovenia 25,261.3 (21,961.9-28,537.4) 1,221.0 (1,061.6-
1,379.4) 
718.5 (626.1-808.9) 
Solomon Islands 3,756.4 (3,247.8-4,263.9) 589.1 (509.4-668.7) 864.6 (750.7-976.2) 
Somalia 140,614.0 (123,897.2-
157,434.9) 
833.0 (734.0-932.6) 1,672.9 (1,473.8-1,873.3) 

















499.3 (430.7-567.7) 275.4 (237.9-312.3) 
Sri Lanka 176,731.5 (153,222.9-
199,642.4) 






Suriname 7,650.3 (6,702.6-8,582.1) 1,336.4 (1,170.8-
1,499.1) 
1,307.4 (1,146.4-1,465.3) 
Swaziland 9,016.6 (7,862.2-10,159.0) 801.9 (699.2-903.5) 1,274.8 (1,112.0-1,435.1) 
Sweden 32,875.4 (28,520.6-37,125.3) 327.3 (283.9-369.6) 199.2 (173.0-224.7) 
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The Bahamas 3,663.8 (3,197.4-4,120.7) 975.9 (851.6-
1,097.6) 
943.8 (823.9-1,060.8) 
The Gambia 23,692.6 (20,882.7-26,500.1) 1,111.0 (979.3-
1,242.7) 
1,975.1 (1,737.1-2,211.7) 
Timor-Leste 10,518.2 (9,185.3-11,831.7) 817.0 (713.4-919.0) 1,164.9 (1,016.7-1,311.1) 
Togo 92,200.8 (81,046.7-103,259.0) 1,226.7 (1,078.3-
1,373.9) 
2,053.2 (1,808.8-2,295.4) 
Tonga 728.1 (630.7-822.9) 708.0 (613.3-800.2) 841.1 (729.5-949.9) 































United Kingdom 339,801.9 (293,945.2-
384,779.8) 
509.9 (441.1-577.4) 311.5 (270.5-351.6) 
United States 1,477,702.7 (1,282,213.5-
1,667,640.9) 
454.9 (394.7-513.4) 310.0 (269.6-349.3) 
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763.4 (670.2-855.0) 1,494.6 (1,311.1-1,677.9) 
Zimbabwe 119,934.9 (104,820.7-
134,811.5) 
815.1 (712.4-916.2) 1,403.3 (1,226.5-1,577.2) 
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Table S3:  Estimates of the disability adjusted life-years (DALYs) of CKD attributable to PM2.5 for 194 countries and territories. 
Geography DALY number (95% UI) DALY rate 
(per 100,000) (95% 
UI) 
Age-standardized 
DALY rate (per 




89.9 (77.8-101.3) 101.6 (87.6-115.0) 
World Bank Low Income 
572,842.5 (464,496.4-
673,714.7) 
78.9 (63.9-92.9) 127.0 (103.5-148.8) 
World Bank Lower Middle 
3,679,581.5 (3,190,544.4-
4,151,025.5) 
121.4 (105.3-136.9) 149.1 (128.8-168.7) 
World Bank Upper Middle 
1,973,883.5 (1,738,137.4-
2,205,780.9) 
75.5 (66.5-84.4) 66.2 (58.4-73.9) 
World Bank High Income 
366,827.1 (310,526.8-
421,111.7) 
32.9 (27.5-37.9) 25.6 (21.3-29.7) 
Afghanistan 42,664.9 (34,426.2-50,685.0) 129.9 (104.8-154.3) 231.3 (190.2-269.6) 
Albania 1,072.1 (859.3-1,270.9) 38.8 (31.1-45.9) 29.6 (23.8-35.0) 
Algeria 27,677.4 (23,550.5-31,590.6) 68.4 (58.2-78.1) 78.9 (67.3-89.8) 
American Samoa 51.8 (44.1-59.6) 93.1 (79.2-107.1) 112.1 (95.7-128.7) 
Andorra 8.1 (6.4-9.6) 10.1 (8.1-12.0) 6.3 (5.0-7.5) 
Angola 18,994.3 (15,682.9-22,152.0) 67.4 (55.6-78.5) 124.6 (103.8-144.5) 
Antigua and Barbuda 78.2 (68.0-88.4) 87.9 (76.5-99.4) 78.1 (68.0-88.2) 
Argentina 18,516.7 (15,766.1-21,264.5) 41.8 (35.6-48.0) 35.9 (30.6-41.2) 
Armenia 1,984.5 (1,719.7-2,238.8) 65.6 (56.8-74.0) 50.8 (44.0-57.3) 
Australia 3,448.4 (2,916.1-3,975.3) 14.4 (12.2-16.6) 8.8 (7.4-10.2) 
Austria 2,680.7 (2,318.0-3,043.3) 30.5 (26.4-34.6) 15.0 (12.9-17.2) 
Azerbaijan 4,921.6 (4,203.8-5,617.8) 48.1 (41.1-54.9) 50.2 (42.8-57.3) 
Bahrain 1,367.9 (1,137.9-1,580.4) 93.0 (77.4-107.5) 135.0 (115.3-153.8) 
Bangladesh 145,226.0 (124,595.2-
164,950.4) 
92.5 (79.4-105.1) 108.4 (93.3-122.9) 
Barbados 296.9 (254.3-338.0) 100.3 (86.0-114.2) 69.4 (59.5-79.1) 
Belarus 1,945.3 (1,574.7-2,293.7) 20.5 (16.6-24.2) 13.8 (11.2-16.3) 
Belgium 2,573.9 (2,183.3-2,963.0) 22.7 (19.3-26.2) 11.7 (9.8-13.5) 
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Belize 367.1 (324.2-408.8) 92.9 (82.1-103.5) 119.0 (105.1-132.6) 
Benin 10,314.5 (8,132.7-12,417.7) 89.0 (70.2-107.2) 142.1 (113.1-170.0) 
Bermuda 26.3 (22.5-30.1) 39.9 (34.1-45.7) 23.8 (20.3-27.3) 
Bhutan 846.6 (666.2-1,020.4) 88.4 (69.6-106.6) 116.8 (93.0-139.6) 
Bolivia 9,964.6 (7,815.9-11,945.5) 86.3 (67.7-103.5) 109.0 (85.8-130.4) 
Bosnia and Herzegovina 2,245.2 (1,929.9-2,546.3) 66.1 (56.8-74.9) 40.9 (35.2-46.4) 
Botswana 1,054.3 (868.9-1,231.4) 46.2 (38.1-54.0) 68.0 (56.1-79.3) 
Brazil 72,378.7 (63,391.6-81,130.5) 34.2 (29.9-38.3) 31.9 (28.0-35.8) 
Brunei 63.4 (53.9-72.8) 14.7 (12.5-16.8) 17.7 (15.1-20.3) 
Bulgaria 4,095.4 (3,551.5-4,639.1) 58.1 (50.4-65.8) 33.8 (29.4-38.2) 
Burkina Faso 22,812.7 (18,731.2-26,612.0) 108.0 (88.7-126.0) 171.3 (143.7-197.9) 
Burundi 7,223.0 (5,762.3-8,626.9) 66.2 (52.8-79.1) 125.2 (101.2-147.5) 
Cambodia 9,188.6 (7,618.6-10,677.1) 57.0 (47.3-66.2) 70.4 (58.8-81.4) 
Cameroon 35,979.4 (28,902.7-42,927.7) 129.6 (104.1-154.6) 208.5 (167.9-248.4) 
Canada 3,679.1 (3,093.6-4,254.3) 10.2 (8.6-11.8) 6.0 (5.0-7.0) 
Cape Verde 373.6 (317.9-426.6) 68.5 (58.2-78.2) 76.2 (64.9-86.9) 
Central African Republic 6,414.4 (5,056.7-7,750.6) 138.8 (109.4-167.7) 217.8 (174.6-260.1) 
Chad 18,874.3 (15,515.7-22,054.6) 124.0 (101.9-144.9) 192.5 (157.9-225.7) 
Chile 10,887.3 (9,275.5-12,445.1) 60.8 (51.8-69.5) 48.2 (41.1-55.1) 
China 1,123,422.3 (995,274.0-
1,247,673.2) 
79.5 (70.5-88.3) 60.7 (53.8-67.3) 
Colombia 21,917.7 (18,587.1-25,172.2) 43.3 (36.7-49.7) 41.2 (34.9-47.3) 
Comoros 380.0 (310.3-446.4) 52.9 (43.2-62.1) 74.3 (60.9-87.0) 
Congo 5,085.7 (4,010.8-6,135.0) 103.5 (81.6-124.9) 164.7 (133.6-194.0) 
Costa Rica 2,870.8 (2,477.7-3,263.6) 61.7 (53.2-70.1) 58.0 (50.1-65.9) 
Cote d'Ivoire 17,806.0 (14,390.4-21,003.2) 71.3 (57.6-84.1) 110.5 (88.9-130.6) 
Croatia 1,680.1 (1,456.9-1,903.7) 39.3 (34.1-44.5) 20.4 (17.6-23.2) 
Cuba 7,316.3 (6,215.1-8,382.9) 64.3 (54.6-73.7) 43.4 (36.9-49.7) 
Cyprus 459.4 (364.0-547.7) 36.4 (28.8-43.4) 24.8 (19.8-29.5) 
Czech Republic 2,908.9 (2,474.9-3,338.1) 27.5 (23.4-31.5) 15.7 (13.3-18.1) 
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Democratic Republic of the 
Congo 
65,065.2 (53,305.8-75,961.5) 80.4 (65.9-93.9) 141.4 (116.6-164.6) 
Denmark 1,009.4 (862.4-1,157.4) 17.6 (15.0-20.2) 9.8 (8.3-11.3) 
Djibouti 1,031.0 (719.8-1,323.3) 92.6 (64.7-118.9) 149.5 (108.1-188.2) 
Dominica 94.3 (82.3-106.0) 136.7 (119.4-153.8) 114.0 (99.5-128.3) 
Dominican Republic 5,595.6 (4,486.2-6,618.6) 53.5 (42.9-63.3) 57.8 (46.4-68.4) 
Ecuador 11,614.2 (10,062.8-13,165.0) 69.6 (60.3-78.9) 76.9 (66.6-87.2) 
Egypt 135,079.9 (114,570.9-
154,223.6) 
140.0 (118.7-159.8) 204.7 (173.1-233.9) 
El Salvador 14,293.5 (10,177.1-18,137.1) 234.8 (167.2-298.0) 248.8 (177.3-315.6) 
Equatorial Guinea 1,118.4 (730.6-1,481.3) 83.1 (54.3-110.1) 170.8 (113.7-224.2) 
Eritrea 5,782.6 (4,502.6-7,045.6) 98.7 (76.8-120.2) 174.9 (139.6-209.2) 
Estonia 170.7 (142.3-198.2) 13.0 (10.8-15.1) 7.1 (5.9-8.2) 
Ethiopia 60,996.7 (52,695.9-68,903.7) 59.3 (51.2-67.0) 111.3 (95.5-126.3) 
Federated States of 
Micronesia 
82.9 (61.1-102.9) 79.8 (58.8-99.1) 102.8 (78.0-125.5) 
Fiji 548.7 (459.5-635.1) 60.5 (50.7-70.0) 69.6 (58.3-80.5) 
Finland 317.4 (258.7-371.7) 5.8 (4.7-6.7) 3.0 (2.4-3.5) 
France 10,879.4 (9,032.3-12,634.6) 16.6 (13.7-19.2) 8.4 (6.8-9.9) 
Gabon 1,895.1 (1,544.1-2,221.7) 111.3 (90.7-130.5) 159.7 (131.2-186.2) 
Georgia 2,708.3 (2,353.8-3,068.2) 73.4 (63.8-83.1) 52.0 (45.2-58.8) 
Germany 26,641.6 (22,628.8-30,645.3) 32.0 (27.2-36.8) 14.3 (12.1-16.5) 
Ghana 27,048.7 (22,028.8-31,740.7) 89.5 (72.9-105.1) 123.3 (101.9-143.6) 
Greece 5,312.5 (4,594.0-6,031.9) 51.1 (44.2-58.0) 23.0 (19.7-26.2) 
Greenland 9.1 (7.4-10.8) 16.3 (13.1-19.2) 14.4 (11.6-17.1) 
Grenada 158.3 (138.8-177.5) 142.8 (125.1-160.1) 116.4 (102.0-130.4) 
Guam 114.3 (97.7-131.1) 68.1 (58.2-78.1) 64.0 (54.7-73.4) 
Guatemala 19,822.9 (17,186.5-22,459.0) 117.1 (101.5-132.7) 160.1 (138.9-181.3) 
Guinea 8,958.0 (7,448.9-10,384.7) 75.8 (63.0-87.9) 115.0 (95.5-133.5) 
Guinea-Bissau 1,808.2 (1,417.0-2,184.6) 97.4 (76.4-117.7) 158.4 (126.0-188.4) 
Guyana 757.1 (636.5-871.2) 102.0 (85.7-117.4) 112.4 (94.5-129.4) 
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Haiti 6,735.5 (5,271.2-8,073.3) 57.0 (44.6-68.3) 79.5 (62.6-95.0) 
Honduras 2,965.1 (2,375.4-3,518.4) 31.2 (25.0-37.0) 44.7 (35.7-53.1) 
Hungary 3,185.4 (2,726.0-3,645.7) 32.7 (28.0-37.5) 18.5 (15.8-21.2) 
Iceland 17.5 (14.2-20.5) 5.2 (4.2-6.1) 3.5 (2.8-4.1) 
India 2,170,260.6 (1,947,832.7-
2,382,115.9) 
157.2 (141.1-172.5) 183.0 (164.2-200.9) 
Indonesia 124,597.0 (108,776.9-
140,094.4) 
48.3 (42.1-54.3) 51.8 (45.2-58.3) 
Iran 58,399.9 (50,920.3-65,594.6) 71.1 (62.0-79.8) 80.7 (70.8-90.5) 
Iraq 45,493.7 (39,506.5-51,262.4) 105.1 (91.2-118.4) 153.1 (133.5-171.9) 
Ireland 464.0 (389.6-536.6) 9.5 (8.0-11.0) 6.7 (5.6-7.7) 
Israel 4,503.0 (3,909.8-5,100.0) 50.3 (43.7-57.0) 40.5 (35.0-46.0) 
Italy 20,705.8 (17,608.6-23,747.2) 34.2 (29.1-39.2) 14.8 (12.3-17.1) 
Jamaica 1,783.7 (1,451.3-2,094.9) 64.2 (52.2-75.4) 61.4 (50.0-72.1) 
Japan 45,997.9 (38,527.6-53,228.8) 35.8 (30.0-41.5) 15.0 (12.2-17.6) 
Jordan 7,025.2 (5,964.9-8,032.1) 66.0 (56.0-75.4) 106.4 (90.3-121.6) 
Kazakhstan 4,495.8 (3,874.1-5,117.4) 25.1 (21.6-28.6) 25.5 (22.0-29.0) 
Kenya 25,040.7 (21,567.9-28,362.6) 51.8 (44.6-58.7) 92.2 (79.3-104.5) 
Kiribati 63.5 (49.8-76.1) 53.7 (42.1-64.3) 73.8 (58.3-88.0) 
Kuwait 2,253.5 (1,816.9-2,682.2) 52.9 (42.6-62.9) 69.3 (57.4-80.4) 
Kyrgyzstan 2,693.1 (2,346.3-3,037.3) 42.3 (36.8-47.7) 49.0 (42.6-55.3) 
Laos 5,406.2 (4,327.4-6,411.1) 77.6 (62.1-92.0) 101.4 (82.4-119.3) 
Latvia 532.8 (445.9-616.4) 27.4 (22.9-31.7) 15.7 (13.1-18.1) 
Lebanon 3,306.4 (2,716.0-3,866.1) 38.8 (31.9-45.4) 50.3 (41.8-58.6) 
Lesotho 2,070.8 (1,613.7-2,510.0) 106.3 (82.9-128.9) 149.1 (117.1-179.4) 
Liberia 2,247.3 (1,745.0-2,710.0) 47.6 (36.9-57.4) 75.5 (59.8-90.1) 
Libya 8,544.4 (7,097.2-9,896.1) 123.7 (102.7-143.2) 164.4 (137.6-189.9) 
Lithuania 513.3 (426.7-595.8) 18.0 (15.0-20.9) 10.6 (8.8-12.3) 
Luxembourg 91.5 (76.6-105.9) 15.5 (13.0-17.9) 9.8 (8.2-11.4) 
Macedonia 1,390.7 (1,191.2-1,579.4) 63.9 (54.8-72.6) 44.4 (38.0-50.4) 
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Madagascar 10,771.8 (8,642.1-12,770.4) 41.3 (33.1-48.9) 74.0 (60.0-87.4) 
Malawi 8,690.4 (7,163.9-10,148.9) 50.6 (41.7-59.0) 87.4 (72.3-101.6) 
Malaysia 12,503.6 (10,623.0-14,356.9) 40.8 (34.7-46.9) 47.1 (40.2-53.9) 
Maldives 76.5 (65.1-87.9) 16.7 (14.2-19.2) 23.4 (20.0-26.8) 
Mali 20,094.9 (16,017.8-24,015.2) 99.2 (79.1-118.6) 133.6 (109.0-156.5) 
Malta 146.9 (126.3-167.6) 33.8 (29.1-38.6) 18.3 (15.6-20.9) 
Marshall Islands 40.8 (31.9-49.0) 72.5 (56.7-87.0) 99.4 (78.7-118.4) 
Mauritania 3,533.9 (2,872.9-4,158.8) 90.3 (73.4-106.3) 137.3 (111.3-162.0) 
Mauritius 2,367.7 (2,051.3-2,683.5) 186.1 (161.3-210.9) 142.6 (123.6-161.5) 
Mexico 211,185.7 (188,782.8-
233,381.8) 
166.9 (149.2-184.4) 177.1 (158.4-195.7) 
Moldova 846.1 (703.7-978.9) 22.7 (18.9-26.3) 16.7 (13.9-19.2) 
Mongolia 2,639.4 (2,139.1-3,104.4) 81.2 (65.8-95.5) 94.6 (78.3-110.1) 
Montenegro 343.5 (291.8-393.6) 54.8 (46.6-62.8) 37.1 (31.7-42.4) 
Morocco 24,251.7 (19,825.1-28,415.5) 68.3 (55.9-80.1) 74.8 (61.2-87.6) 
Mozambique 13,375.3 (10,556.2-15,984.9) 44.5 (35.1-53.2) 80.2 (61.4-97.9) 
Myanmar 69,750.0 (57,807.6-81,165.4) 132.1 (109.5-153.7) 142.7 (119.3-165.1) 
Namibia 1,052.6 (849.3-1,242.8) 44.7 (36.1-52.8) 66.4 (53.8-78.2) 
Nepal 47,203.2 (37,838.6-56,255.5) 157.9 (126.6-188.2) 199.0 (160.1-236.6) 
Netherlands 3,217.4 (2,703.8-3,717.3) 18.9 (15.9-21.8) 10.3 (8.5-12.0) 
New Zealand 406.9 (351.9-461.1) 9.1 (7.9-10.4) 5.8 (5.0-6.6) 
Nicaragua 7,068.1 (5,674.9-8,365.9) 110.5 (88.7-130.8) 139.9 (113.3-164.9) 
Niger 26,043.6 (20,248.9-31,561.5) 121.8 (94.7-147.6) 195.1 (154.8-233.6) 
Nigeria 182,496.0 (136,061.0-
226,156.7) 
88.6 (66.0-109.7) 127.5 (93.2-159.7) 
North Korea 21,075.2 (17,279.8-24,658.5) 82.0 (67.2-95.9) 69.1 (56.7-80.9) 
Northern Mariana Islands 28.3 (23.8-32.8) 63.1 (53.1-73.0) 54.6 (46.5-62.7) 
Norway 381.4 (322.7-440.0) 7.2 (6.1-8.4) 4.4 (3.7-5.1) 
Oman 2,268.2 (1,831.3-2,681.1) 50.0 (40.4-59.1) 88.4 (71.1-104.8) 
Pakistan 338,241.0 (269,104.1-
406,467.7) 
157.8 (125.6-189.7) 226.6 (180.7-271.9) 
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Palestine 3,486.6 (3,039.7-3,927.2) 71.9 (62.6-80.9) 120.6 (105.4-135.7) 
Panama 1,597.3 (1,382.9-1,808.6) 40.7 (35.3-46.1) 40.4 (35.0-45.8) 
Papua New Guinea 5,974.9 (4,593.9-7,240.3) 64.8 (49.8-78.5) 93.3 (72.9-111.9) 
Paraguay 2,968.5 (2,342.8-3,541.2) 42.8 (33.8-51.1) 53.1 (41.8-63.5) 
Peru 18,397.3 (15,292.4-21,331.6) 55.4 (46.0-64.2) 58.6 (48.7-68.1) 
Philippines 114,242.8 (95,112.1-132,161.5) 110.4 (91.9-127.7) 137.7 (115.1-159.0) 
Poland 11,191.8 (9,472.6-12,842.6) 29.2 (24.7-33.5) 18.0 (15.2-20.7) 
Portugal 2,248.6 (1,925.0-2,572.2) 21.1 (18.0-24.1) 9.9 (8.5-11.4) 
Puerto Rico 1,642.6 (1,420.9-1,858.7) 44.8 (38.8-50.7) 26.9 (23.3-30.4) 
Qatar 1,724.6 (1,377.7-2,059.9) 62.8 (50.1-75.0) 149.8 (121.8-177.4) 
Romania 6,574.0 (5,679.7-7,468.2) 33.8 (29.2-38.4) 19.9 (17.1-22.6) 
Russian Federation 39,212.9 (33,237.9-45,054.1) 26.8 (22.7-30.8) 19.0 (16.1-21.8) 
Rwanda 8,160.6 (6,664.4-9,547.9) 65.0 (53.1-76.1) 113.7 (92.9-132.9) 
Saint Lucia 194.3 (169.0-220.0) 110.1 (95.8-124.7) 94.4 (82.1-106.8) 
Saint Vincent and the 
Grenadines 
134.9 (117.4-152.2) 118.2 (102.9-133.4) 103.1 (90.0-116.2) 
Samoa 103.0 (83.3-121.3) 51.8 (41.9-61.0) 70.8 (57.8-83.1) 
Sao Tome and Principe 243.1 (201.6-282.7) 121.4 (100.7-141.2) 175.7 (145.5-204.5) 
Saudi Arabia 40,837.3 (33,628.5-47,849.9) 118.6 (97.6-138.9) 198.1 (164.2-230.2) 
Senegal 13,962.2 (11,352.5-16,382.8) 95.1 (77.3-111.5) 144.6 (118.3-169.1) 
Serbia 6,556.5 (5,581.2-7,480.9) 73.9 (62.9-84.3) 43.2 (37.0-49.1) 
Seychelles 127.3 (111.2-143.1) 126.1 (110.2-141.8) 116.7 (102.0-131.1) 
Sierra Leone 4,837.5 (3,926.1-5,705.0) 61.8 (50.1-72.9) 88.9 (72.5-104.6) 
Singapore 1,924.5 (1,631.2-2,209.4) 34.6 (29.3-39.7) 28.5 (24.2-32.7) 
Slovakia 1,851.9 (1,581.6-2,118.5) 34.2 (29.2-39.1) 22.1 (18.9-25.3) 
Slovenia 441.4 (365.3-512.9) 21.3 (17.7-24.8) 11.3 (9.2-13.2) 
Solomon Islands 425.8 (338.7-505.7) 66.8 (53.1-79.3) 93.8 (76.2-110.3) 
Somalia 13,088.1 (9,223.5-16,707.6) 77.5 (54.6-99.0) 147.7 (107.8-185.5) 
South Africa 37,895.5 (33,356.7-42,316.2) 69.0 (60.7-77.0) 79.6 (70.0-89.0) 
South Korea 22,991.6 (19,377.2-26,415.9) 43.7 (36.8-50.2) 28.7 (24.2-33.1) 
Supplementary material BMJ Global Health
 doi: 10.1136/bmjgh-2019-002063:e002063. 5 2020;BMJ Global Health, et al. Bowe B
36 
 
South Sudan 10,211.3 (7,577.9-12,697.5) 102.7 (76.2-127.7) 183.9 (136.1-228.8) 
Spain 8,250.9 (7,008.5-9,492.7) 17.8 (15.1-20.5) 8.6 (7.2-9.9) 
Sri Lanka 7,933.6 (6,346.2-9,395.8) 36.7 (29.4-43.5) 32.7 (26.3-38.7) 
Sudan 32,351.6 (25,829.1-38,746.3) 80.4 (64.2-96.3) 121.6 (99.7-142.1) 
Suriname 811.2 (696.1-922.3) 141.7 (121.6-161.1) 137.9 (118.8-156.7) 
Swaziland 761.3 (559.3-948.6) 67.7 (49.7-84.4) 106.9 (79.5-132.2) 
Sweden 738.4 (619.7-855.1) 7.4 (6.2-8.5) 3.8 (3.1-4.5) 
Switzerland 1,377.2 (1,156.9-1,592.7) 16.0 (13.5-18.5) 8.2 (6.7-9.6) 
Syria 15,357.7 (12,636.4-17,896.8) 84.7 (69.7-98.7) 108.5 (88.8-126.8) 
Tajikistan 6,412.2 (5,517.6-7,266.7) 69.4 (59.7-78.6) 88.3 (75.7-100.3) 
Tanzania 32,267.1 (27,026.2-37,201.0) 59.8 (50.1-68.9) 97.1 (81.4-111.9) 
Thailand 77,069.9 (65,692.3-87,811.7) 109.1 (93.0-124.3) 81.6 (69.7-92.9) 
The Bahamas 295.3 (255.1-335.7) 78.6 (68.0-89.4) 75.4 (65.3-85.5) 
The Gambia 1,631.4 (1,261.3-1,986.1) 76.5 (59.1-93.1) 123.8 (98.9-147.1) 
Timor-Leste 550.7 (418.4-674.2) 42.8 (32.5-52.4) 59.9 (46.0-72.7) 
Togo 5,736.8 (4,594.3-6,812.4) 76.3 (61.1-90.6) 117.2 (94.9-137.8) 
Tonga 62.9 (49.8-74.9) 61.2 (48.5-72.8) 74.7 (59.3-88.8) 
Trinidad and Tobago 1,766.3 (1,415.4-2,093.6) 126.9 (101.7-150.4) 101.6 (81.6-120.3) 
Tunisia 8,259.2 (6,730.9-9,676.8) 72.2 (58.8-84.6) 69.6 (56.9-81.4) 
Turkey 85,112.2 (73,113.4-96,547.4) 105.8 (90.9-120.0) 99.1 (85.2-112.3) 
Turkmenistan 3,142.2 (2,742.0-3,540.0) 63.1 (55.1-71.1) 69.3 (60.5-78.0) 
Uganda 25,660.6 (21,240.3-29,784.7) 65.7 (54.4-76.2) 131.4 (109.9-151.8) 
Ukraine 12,311.8 (10,274.9-14,227.7) 27.5 (23.0-31.8) 19.3 (16.2-22.1) 
United Arab Emirates 7,903.1 (6,101.5-9,666.5) 81.2 (62.7-99.3) 142.5 (113.3-170.7) 
United Kingdom 8,493.1 (7,024.8-9,882.9) 12.7 (10.5-14.8) 7.5 (6.1-8.8) 
United States 72,699.1 (62,984.8-82,168.5) 22.4 (19.4-25.3) 14.6 (12.6-16.6) 
Uruguay 811.9 (692.4-932.5) 23.7 (20.2-27.3) 16.1 (13.7-18.5) 
Uzbekistan 23,270.5 (19,851.9-26,512.9) 72.2 (61.6-82.2) 83.7 (71.5-95.2) 
Vanuatu 155.6 (110.3-197.9) 54.1 (38.3-68.8) 78.2 (56.9-97.9) 
Venezuela 22,712.6 (18,917.2-26,258.7) 73.7 (61.4-85.2) 78.1 (65.3-90.2) 
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Vietnam 73,817.3 (61,794.6-85,173.1) 76.8 (64.3-88.6) 78.3 (65.8-90.0) 
Virgin Islands, U.S. 69.5 (57.6-80.8) 66.2 (54.8-77.0) 41.5 (34.5-48.1) 
Yemen 20,087.9 (15,288.3-24,695.7) 66.0 (50.2-81.1) 112.7 (88.3-136.8) 
Zambia 10,164.1 (8,508.3-11,717.8) 58.5 (49.0-67.5) 110.6 (92.9-127.3) 
Zimbabwe 7,897.4 (6,438.1-9,290.7) 53.7 (43.8-63.1) 92.8 (76.1-108.7) 
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Table S4:  Estimates of death attributable to PM2.5 for 194 countries and territories. 
Geography Death number (95% UI) Death (per 
100,000) (95% UI) 
Age-standardized death 





2.9 (2.5-3.2) 3.8 (3.2-4.3) 
World Bank Low Income 
14,794.7 (11,911.0-
17,530.8) 
2.0 (1.6-2.4) 4.8 (3.9-5.7) 
World Bank Lower Middle 
107,956.0 (93,800.7-
121,573.2) 
3.6 (3.1-4.0) 5.4 (4.6-6.1) 
World Bank Upper Middle 
70,735.6 (62,833.2-
78,339.8) 
2.7 (2.4-3.0) 2.5 (2.2-2.8) 
World Bank High Income 
17,532.9 (15,310.4-
19,737.9) 
1.6 (1.4-1.8) 1.1 (0.9-1.3) 
Afghanistan 934.2 (753.3-1,110.5) 2.8 (2.3-3.4) 8.2 (6.7-9.6) 
Albania 38.7 (29.5-47.3) 1.4 (1.1-1.7) 1.0 (0.8-1.2) 
Algeria 873.4 (745.7-994.7) 2.2 (1.8-2.5) 3.0 (2.5-3.4) 
American Samoa 1.7 (1.5-2.0) 3.1 (2.6-3.6) 4.8 (4.0-5.5) 
Andorra 0.3 (0.3-0.4) 0.4 (0.3-0.5) 0.2 (0.2-0.3) 
Angola 473.2 (385.9-555.2) 1.7 (1.4-2.0) 5.0 (4.1-5.9) 
Antigua and Barbuda 2.8 (2.5-3.2) 3.2 (2.8-3.6) 2.9 (2.5-3.2) 
Argentina 852.7 (728.7-977.9) 1.9 (1.6-2.2) 1.6 (1.3-1.8) 
Armenia 72.5 (64.9-79.8) 2.4 (2.1-2.6) 1.8 (1.6-2.0) 
Australia 208.7 (179.2-238.4) 0.9 (0.7-1.0) 0.4 (0.4-0.5) 
Austria 202.7 (177.2-227.7) 2.3 (2.0-2.6) 0.9 (0.8-1.0) 
Azerbaijan 135.0 (113.3-155.5) 1.3 (1.1-1.5) 1.6 (1.4-1.9) 
Bahrain 35.6 (30.4-40.5) 2.4 (2.1-2.8) 6.0 (5.1-6.8) 
Bangladesh 4,168.4 (3,547.7-4,760.5) 2.7 (2.3-3.0) 3.8 (3.3-4.3) 
Barbados 11.7 (10.2-13.2) 4.0 (3.4-4.5) 2.5 (2.1-2.8) 
Belarus 53.3 (46.6-60.0) 0.6 (0.5-0.6) 0.3 (0.3-0.4) 
Belgium 159.7 (138.8-180.3) 1.4 (1.2-1.6) 0.5 (0.5-0.6) 
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Belize 11.0 (9.8-12.2) 2.8 (2.5-3.1) 4.1 (3.7-4.6) 
Benin 246.9 (193.0-298.9) 2.1 (1.7-2.6) 5.0 (3.9-6.0) 
Bermuda 1.1 (1.0-1.3) 1.7 (1.4-1.9) 0.9 (0.8-1.0) 
Bhutan 25.5 (19.8-31.0) 2.7 (2.1-3.2) 4.4 (3.4-5.3) 
Bolivia 391.4 (305.5-471.0) 3.4 (2.6-4.1) 4.9 (3.9-5.9) 
Bosnia and Herzegovina 90.8 (78.5-102.9) 2.7 (2.3-3.0) 1.6 (1.4-1.8) 
Botswana 34.5 (28.3-40.5) 1.5 (1.2-1.8) 2.9 (2.4-3.4) 
Brazil 2,648.0 (2,367.0-2,935.4) 1.3 (1.1-1.4) 1.2 (1.1-1.3) 
Brunei 1.9 (1.6-2.2) 0.4 (0.4-0.5) 0.7 (0.6-0.8) 
Bulgaria 161.2 (140.9-181.1) 2.3 (2.0-2.6) 1.1 (1.0-1.3) 
Burkina Faso 562.7 (468.7-652.6) 2.7 (2.2-3.1) 6.5 (5.4-7.5) 
Burundi 185.5 (148.6-220.7) 1.7 (1.4-2.0) 5.2 (4.2-6.1) 
Cambodia 260.2 (216.1-302.0) 1.6 (1.3-1.9) 2.4 (2.0-2.8) 
Cameroon 879.8 (694.8-1,058.6) 3.2 (2.5-3.8) 7.6 (6.0-9.1) 
Canada 186.5 (162.4-209.8) 0.5 (0.5-0.6) 0.2 (0.2-0.3) 
Cape Verde 11.5 (9.9-13.0) 2.1 (1.8-2.4) 2.4 (2.1-2.7) 
Central African Republic 156.9 (122.8-190.2) 3.4 (2.7-4.1) 7.9 (6.3-9.4) 
Chad 405.7 (329.1-481.1) 2.7 (2.2-3.2) 6.5 (5.2-7.7) 
Chile 510.4 (438.4-581.2) 2.8 (2.4-3.2) 2.2 (1.9-2.5) 
China 40,434.7 (36,298.0-
44,514.9) 
2.9 (2.6-3.2) 2.3 (2.1-2.5) 
Colombia 829.6 (711.7-948.5) 1.6 (1.4-1.9) 1.5 (1.3-1.7) 
Comoros 12.4 (9.9-14.6) 1.7 (1.4-2.0) 3.1 (2.5-3.7) 
Congo 143.5 (113.5-172.7) 2.9 (2.3-3.5) 6.7 (5.4-7.9) 
Costa Rica 117.7 (102.2-133.2) 2.5 (2.2-2.9) 2.4 (2.1-2.7) 
Cote d'Ivoire 404.9 (319.0-484.8) 1.6 (1.3-1.9) 3.8 (3.0-4.6) 
Croatia 87.2 (76.5-97.8) 2.0 (1.8-2.3) 0.9 (0.8-1.0) 
Cuba 267.8 (228.9-305.6) 2.4 (2.0-2.7) 1.4 (1.2-1.7) 
Cyprus 26.1 (20.1-31.6) 2.1 (1.6-2.5) 1.3 (1.0-1.6) 
Czech Republic 119.9 (104.9-134.7) 1.1 (1.0-1.3) 0.6 (0.5-0.6) 
Supplementary material BMJ Global Health
 doi: 10.1136/bmjgh-2019-002063:e002063. 5 2020;BMJ Global Health, et al. Bowe B
40 
 
Democratic Republic of the 
Congo 
1,677.2 (1,362.4-1,973.5) 2.1 (1.7-2.4) 5.6 (4.6-6.5) 
Denmark 55.0 (48.0-62.0) 1.0 (0.8-1.1) 0.4 (0.4-0.5) 
Djibouti 29.3 (20.3-37.8) 2.6 (1.8-3.4) 6.5 (4.7-8.1) 
Dominica 3.7 (3.3-4.2) 5.4 (4.7-6.1) 4.1 (3.5-4.6) 
Dominican Republic 187.4 (147.5-224.0) 1.8 (1.4-2.1) 2.0 (1.6-2.4) 
Ecuador 507.5 (438.4-576.5) 3.0 (2.6-3.5) 3.6 (3.1-4.0) 
Egypt 3,823.3 (3,186.2-4,415.8) 4.0 (3.3-4.6) 8.4 (7.0-9.8) 
El Salvador 561.9 (405.0-708.8) 9.2 (6.7-11.6) 9.8 (7.0-12.3) 
Equatorial Guinea 31.0 (19.6-41.8) 2.3 (1.5-3.1) 7.5 (5.0-9.8) 
Eritrea 139.5 (109.0-169.5) 2.4 (1.9-2.9) 6.6 (5.3-7.9) 
Estonia 8.8 (7.4-10.2) 0.7 (0.6-0.8) 0.3 (0.2-0.3) 
Ethiopia 1,736.0 (1,483.8-1,975.8) 1.7 (1.4-1.9) 4.8 (4.1-5.4) 
Federated States of 
Micronesia 
2.5 (1.9-3.1) 2.4 (1.9-3.0) 4.1 (3.2-4.9) 
Fiji 17.3 (14.2-20.2) 1.9 (1.6-2.2) 2.8 (2.3-3.2) 
Finland 15.3 (13.3-17.2) 0.3 (0.2-0.3) 0.1 (0.1-0.1) 
France 640.8 (557.4-722.7) 1.0 (0.8-1.1) 0.3 (0.3-0.4) 
Gabon 61.5 (50.4-71.9) 3.6 (3.0-4.2) 6.7 (5.5-7.8) 
Georgia 99.2 (87.5-110.8) 2.7 (2.4-3.0) 1.7 (1.5-1.9) 
Germany 1,882.8 (1,609.6-2,158.9) 2.3 (1.9-2.6) 0.8 (0.7-0.9) 
Ghana 631.1 (517.1-738.5) 2.1 (1.7-2.4) 3.9 (3.2-4.5) 
Greece 343.5 (299.5-386.5) 3.3 (2.9-3.7) 1.2 (1.0-1.3) 
Greenland 0.3 (0.2-0.4) 0.5 (0.4-0.7) 0.6 (0.4-0.7) 
Grenada 6.5 (5.7-7.3) 5.9 (5.2-6.6) 4.2 (3.7-4.7) 
Guam 4.0 (3.4-4.7) 2.4 (2.0-2.8) 2.4 (2.0-2.8) 
Guatemala 684.2 (591.7-776.3) 4.0 (3.5-4.6) 6.5 (5.6-7.3) 
Guinea 229.6 (189.2-268.4) 1.9 (1.6-2.3) 4.0 (3.3-4.7) 
Guinea-Bissau 41.3 (32.2-50.0) 2.2 (1.7-2.7) 5.4 (4.3-6.5) 
Guyana 23.0 (19.2-26.7) 3.1 (2.6-3.6) 3.8 (3.2-4.4) 
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Haiti 185.4 (143.7-223.7) 1.6 (1.2-1.9) 2.8 (2.2-3.4) 
Honduras 88.5 (68.8-106.7) 0.9 (0.7-1.1) 1.5 (1.2-1.9) 
Hungary 146.3 (128.6-163.7) 1.5 (1.3-1.7) 0.7 (0.6-0.8) 
Iceland 0.8 (0.7-0.9) 0.2 (0.2-0.3) 0.1 (0.1-0.2) 
India 66,323.9 (59,842.9-
72,466.1) 
4.8 (4.3-5.2) 6.6 (6.0-7.3) 
Indonesia 3,459.0 (3,015.9-3,892.5) 1.3 (1.2-1.5) 1.7 (1.5-1.9) 
Iran 1,942.5 (1,735.6-2,140.3) 2.4 (2.1-2.6) 3.2 (2.8-3.5) 
Iraq 1,176.7 (1,028.6-1,319.4) 2.7 (2.4-3.0) 5.5 (4.8-6.2) 
Ireland 25.4 (22.0-28.9) 0.5 (0.5-0.6) 0.3 (0.3-0.4) 
Israel 275.2 (241.3-308.5) 3.1 (2.7-3.4) 2.2 (1.9-2.4) 
Italy 1,418.4 (1,240.7-1,593.7) 2.3 (2.0-2.6) 0.7 (0.6-0.8) 
Jamaica 64.2 (52.0-75.6) 2.3 (1.9-2.7) 2.2 (1.8-2.6) 
Japan 2,442.3 (2,136.5-2,739.1) 1.9 (1.7-2.1) 0.5 (0.4-0.6) 
Jordan 218.6 (183.5-251.9) 2.1 (1.7-2.4) 4.7 (4.0-5.4) 
Kazakhstan 121.5 (106.4-136.4) 0.7 (0.6-0.8) 0.8 (0.7-0.9) 
Kenya 721.5 (617.3-819.9) 1.5 (1.3-1.7) 3.9 (3.3-4.5) 
Kiribati 1.7 (1.3-2.0) 1.4 (1.1-1.7) 2.6 (2.0-3.1) 
Kuwait 43.9 (37.5-50.0) 1.0 (0.9-1.2) 2.1 (1.8-2.4) 
Kyrgyzstan 58.1 (51.1-65.0) 0.9 (0.8-1.0) 1.2 (1.0-1.3) 
Laos 145.8 (117.2-172.6) 2.1 (1.7-2.5) 3.5 (2.8-4.1) 
Latvia 20.5 (17.2-23.7) 1.1 (0.9-1.2) 0.5 (0.4-0.6) 
Lebanon 96.1 (80.9-110.4) 1.1 (1.0-1.3) 1.8 (1.5-2.1) 
Lesotho 63.1 (48.8-76.9) 3.2 (2.5-3.9) 5.6 (4.4-6.7) 
Liberia 54.6 (42.0-66.3) 1.2 (0.9-1.4) 2.7 (2.1-3.3) 
Libya 276.2 (227.1-321.9) 4.0 (3.3-4.7) 6.9 (5.7-8.0) 
Lithuania 17.6 (15.4-19.8) 0.6 (0.5-0.7) 0.3 (0.3-0.3) 
Luxembourg 5.0 (4.3-5.8) 0.9 (0.7-1.0) 0.5 (0.4-0.5) 
Macedonia 48.8 (42.0-55.3) 2.2 (1.9-2.5) 1.5 (1.3-1.7) 
Madagascar 265.7 (211.9-316.0) 1.0 (0.8-1.2) 2.8 (2.3-3.3) 
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Malawi 257.3 (213.3-298.9) 1.5 (1.2-1.7) 3.5 (2.9-4.1) 
Malaysia 448.4 (382.2-513.9) 1.5 (1.2-1.7) 2.0 (1.7-2.3) 
Maldives 2.8 (2.4-3.2) 0.6 (0.5-0.7) 1.0 (0.9-1.2) 
Mali 406.4 (325.1-484.2) 2.0 (1.6-2.4) 4.3 (3.4-5.1) 
Malta 7.8 (6.8-8.8) 1.8 (1.6-2.0) 0.8 (0.7-1.0) 
Marshall Islands 1.1 (0.9-1.4) 2.0 (1.6-2.4) 3.8 (3.0-4.5) 
Mauritania 99.4 (78.9-119.4) 2.5 (2.0-3.0) 5.1 (4.1-6.2) 
Mauritius 92.1 (79.8-104.5) 7.2 (6.3-8.2) 5.8 (5.0-6.5) 
Mexico 7,825.0 (7,014.3-8,605.5) 6.2 (5.5-6.8) 7.0 (6.3-7.7) 
Moldova 20.0 (17.6-22.4) 0.5 (0.5-0.6) 0.4 (0.3-0.4) 
Mongolia 63.9 (52.2-74.8) 2.0 (1.6-2.3) 3.0 (2.5-3.4) 
Montenegro 15.2 (12.8-17.4) 2.4 (2.0-2.8) 1.6 (1.3-1.8) 
Morocco 768.7 (614.5-911.8) 2.2 (1.7-2.6) 2.8 (2.2-3.3) 
Mozambique 315.7 (235.2-391.1) 1.1 (0.8-1.3) 3.0 (2.2-3.8) 
Myanmar 2,162.5 (1,797.3-2,513.2) 4.1 (3.4-4.8) 5.1 (4.3-5.9) 
Namibia 35.2 (28.0-41.9) 1.5 (1.2-1.8) 2.7 (2.1-3.2) 
Nepal 1,493.4 (1,186.2-1,785.9) 5.0 (4.0-6.0) 7.4 (5.9-8.8) 
Netherlands 188.8 (164.8-212.3) 1.1 (1.0-1.2) 0.5 (0.4-0.6) 
New Zealand 21.3 (18.8-23.8) 0.5 (0.4-0.5) 0.3 (0.2-0.3) 
Nicaragua 237.4 (194.8-277.4) 3.7 (3.0-4.3) 5.1 (4.2-5.9) 
Niger 533.1 (405.3-653.9) 2.5 (1.9-3.1) 6.5 (4.9-8.0) 
Nigeria 3,698.2 (2,468.9-4,848.1) 1.8 (1.2-2.4) 4.0 (2.7-5.3) 
North Korea 607.7 (488.7-717.3) 2.4 (1.9-2.8) 2.1 (1.7-2.4) 
Northern Mariana Islands 1.0 (0.9-1.2) 2.3 (1.9-2.6) 2.4 (2.0-2.8) 
Norway 20.7 (18.4-23.0) 0.4 (0.3-0.4) 0.2 (0.2-0.2) 
Oman 50.1 (38.9-61.0) 1.1 (0.9-1.3) 3.2 (2.5-4.0) 
Pakistan 8,952.2 (6,995.1-
10,852.0) 
4.2 (3.3-5.1) 8.2 (6.5-10.0) 
Palestine 106.9 (93.9-119.9) 2.2 (1.9-2.5) 4.9 (4.3-5.5) 
Panama 63.2 (55.1-71.1) 1.6 (1.4-1.8) 1.6 (1.4-1.8) 
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Papua New Guinea 142.1 (109.1-172.3) 1.5 (1.2-1.9) 3.1 (2.4-3.7) 
Paraguay 111.7 (86.3-134.8) 1.6 (1.2-1.9) 2.2 (1.7-2.6) 
Peru 730.4 (601.6-853.8) 2.2 (1.8-2.6) 2.3 (1.9-2.7) 
Philippines 3,617.5 (3,003.2-4,192.9) 3.5 (2.9-4.1) 5.3 (4.5-6.2) 
Poland 414.1 (365.5-461.9) 1.1 (1.0-1.2) 0.6 (0.5-0.6) 
Portugal 136.6 (118.2-154.5) 1.3 (1.1-1.4) 0.5 (0.4-0.5) 
Puerto Rico 75.5 (66.0-85.1) 2.1 (1.8-2.3) 1.0 (0.9-1.2) 
Qatar 34.0 (26.8-40.9) 1.2 (1.0-1.5) 7.9 (6.0-9.6) 
Romania 263.7 (231.3-295.4) 1.4 (1.2-1.5) 0.7 (0.6-0.8) 
Russian Federation 1,089.6 (976.8-1,203.5) 0.7 (0.7-0.8) 0.5 (0.4-0.5) 
Rwanda 234.3 (189.3-277.1) 1.9 (1.5-2.2) 4.8 (3.9-5.7) 
Saint Lucia 7.0 (6.1-8.0) 4.0 (3.5-4.5) 3.4 (3.0-3.9) 
Saint Vincent and the 
Grenadines 
4.6 (4.0-5.2) 4.1 (3.5-4.6) 3.4 (3.0-3.8) 
Samoa 3.8 (3.0-4.5) 1.9 (1.5-2.2) 3.1 (2.5-3.7) 
Sao Tome and Principe 7.0 (5.8-8.1) 3.5 (2.9-4.1) 6.8 (5.6-7.9) 
Saudi Arabia 1,117.3 (901.6-1,328.2) 3.2 (2.6-3.9) 8.8 (7.1-10.4) 
Senegal 379.3 (306.8-447.3) 2.6 (2.1-3.0) 5.3 (4.3-6.3) 
Serbia 328.5 (272.2-381.9) 3.7 (3.1-4.3) 2.0 (1.7-2.4) 
Seychelles 4.9 (4.2-5.5) 4.8 (4.2-5.4) 4.8 (4.2-5.5) 
Sierra Leone 110.8 (89.4-131.1) 1.4 (1.1-1.7) 3.0 (2.4-3.5) 
Singapore 66.2 (58.0-74.2) 1.2 (1.0-1.3) 1.0 (0.9-1.1) 
Slovakia 73.9 (64.0-83.8) 1.4 (1.2-1.5) 0.8 (0.7-0.9) 
Slovenia 20.2 (17.4-22.9) 1.0 (0.8-1.1) 0.4 (0.4-0.5) 
Solomon Islands 10.4 (8.4-12.3) 1.6 (1.3-1.9) 3.0 (2.5-3.5) 
Somalia 337.8 (234.6-434.0) 2.0 (1.4-2.6) 6.0 (4.4-7.5) 
South Africa 1,275.8 (1,133.1-1,412.1) 2.3 (2.1-2.6) 3.1 (2.8-3.4) 
South Korea 847.3 (742.3-950.6) 1.6 (1.4-1.8) 1.1 (0.9-1.2) 
South Sudan 262.0 (187.3-331.5) 2.6 (1.9-3.3) 7.5 (5.6-9.3) 
Spain 580.2 (506.5-653.8) 1.3 (1.1-1.4) 0.4 (0.4-0.5) 
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Sri Lanka 290.5 (228.0-347.6) 1.3 (1.1-1.6) 1.3 (1.0-1.5) 
Sudan 750.6 (600.0-898.2) 1.9 (1.5-2.2) 4.2 (3.3-5.0) 
Suriname 28.9 (24.7-32.9) 5.1 (4.3-5.7) 5.2 (4.5-5.9) 
Swaziland 21.6 (15.9-26.8) 1.9 (1.4-2.4) 4.0 (3.0-4.9) 
Sweden 42.6 (37.2-47.8) 0.4 (0.4-0.5) 0.2 (0.1-0.2) 
Switzerland 91.8 (79.9-103.5) 1.1 (0.9-1.2) 0.4 (0.4-0.5) 
Syria 464.7 (366.7-559.9) 2.6 (2.0-3.1) 4.1 (3.2-4.9) 
Tajikistan 136.5 (117.7-154.4) 1.5 (1.3-1.7) 2.4 (2.0-2.7) 
Tanzania 905.2 (750.7-1,052.5) 1.7 (1.4-1.9) 3.9 (3.3-4.6) 
Thailand 3,168.6 (2,671.1-3,641.2) 4.5 (3.8-5.2) 3.4 (2.8-3.9) 
The Bahamas 9.5 (8.2-10.8) 2.5 (2.2-2.9) 2.7 (2.3-3.0) 
The Gambia 42.4 (33.1-51.3) 2.0 (1.6-2.4) 4.4 (3.5-5.2) 
Timor-Leste 16.6 (12.9-20.0) 1.3 (1.0-1.6) 2.2 (1.7-2.6) 
Togo 136.7 (107.7-164.7) 1.8 (1.4-2.2) 4.0 (3.2-4.8) 
Tonga 2.4 (1.9-2.9) 2.3 (1.8-2.8) 3.2 (2.5-3.8) 
Trinidad and Tobago 63.9 (50.5-76.3) 4.6 (3.6-5.5) 3.6 (2.9-4.4) 
Tunisia 307.5 (242.5-370.2) 2.7 (2.1-3.2) 2.9 (2.3-3.4) 
Turkey 3,142.0 (2,683.2-3,581.2) 3.9 (3.3-4.5) 3.7 (3.2-4.2) 
Turkmenistan 78.8 (69.0-88.4) 1.6 (1.4-1.8) 2.0 (1.8-2.2) 
Uganda 676.3 (557.0-787.0) 1.7 (1.4-2.0) 5.5 (4.6-6.3) 
Ukraine 340.5 (301.2-378.7) 0.8 (0.7-0.8) 0.5 (0.4-0.5) 
United Arab Emirates 163.4 (120.2-204.4) 1.7 (1.2-2.1) 6.1 (4.8-7.3) 
United Kingdom 407.9 (364.5-451.8) 0.6 (0.5-0.7) 0.3 (0.2-0.3) 
United States 3,233.7 (2,888.3-3,578.3) 1.0 (0.9-1.1) 0.6 (0.5-0.6) 
Uruguay 40.8 (34.9-46.8) 1.2 (1.0-1.4) 0.7 (0.6-0.8) 
Uzbekistan 550.2 (464.3-631.5) 1.7 (1.4-2.0) 2.4 (2.1-2.8) 
Vanuatu 4.6 (3.2-5.8) 1.6 (1.1-2.0) 3.0 (2.2-3.7) 
Venezuela 843.2 (696.2-980.7) 2.7 (2.3-3.2) 3.1 (2.6-3.6) 
Vietnam 2,744.2 (2,303.6-3,158.1) 2.9 (2.4-3.3) 3.2 (2.7-3.7) 
Virgin Islands, U.S. 2.8 (2.3-3.3) 2.7 (2.2-3.1) 1.6 (1.3-1.9) 
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Yemen 440.6 (326.5-548.0) 1.4 (1.1-1.8) 3.7 (2.8-4.5) 
Zambia 276.2 (229.8-320.1) 1.6 (1.3-1.8) 4.6 (3.9-5.4) 
Zimbabwe 220.9 (176.3-262.5) 1.5 (1.2-1.8) 3.5 (2.9-4.2) 
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Afghanistan 0.29 1.8 
Albania 0.68 0.4 
Algeria 0.70 1.1 
American Samoa 0.70 1.6 
Andorra 0.90 0.5 
Angola 0.46 1.0 
Antigua and Barbuda 0.72 1.2 
Argentina 0.71 0.5 
Armenia 0.70 0.7 
Australia 0.87 0.6 
Austria 0.87 0.9 
Azerbaijan 0.70 0.7 
Bahrain 0.71 2.1 
Bangladesh 0.46 0.8 
Barbados 0.74 1.3 
Belarus 0.77 0.4 
Belgium 0.89 0.8 
Belize 0.60 1.0 
Benin 0.37 1.1 
Bermuda 0.81 0.8 
Bhutan 0.57 1.0 
Bolivia 0.59 0.9 
Bosnia and Herzegovina 0.71 0.6 
Botswana 0.66 0.7 
Brazil 0.66 0.3 
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Brunei Darussalam 0.86 1.0 
Bulgaria 0.79 1.0 
Burkina Faso 0.28 1.3 
Burundi 0.31 1.0 
Cambodia 0.48 0.6 
Cameroon 0.48 1.6 
Canada 0.88 0.4 
Cabo Verde 0.55 0.6 
Central African Republic 0.33 1.7 
Chad 0.25 1.4 
Chile 0.75 1.0 
China 0.71 0.9 
Colombia 0.63 0.4 
Comoros 0.43 0.6 
Congo 0.57 1.4 
Costa Rica 0.66 0.6 
Côte d'Ivoire 0.41 0.9 
Croatia 0.82 0.8 
Cuba 0.69 0.6 
Cyprus 0.86 1.5 
Czech Republic 0.85 0.8 
Congo DRC 0.36 1.1 
Denmark 0.92 0.9 
Djibouti 0.48 1.2 
Dominica 0.69 1.4 
Dominican Republic 0.59 0.5 
Ecuador 0.64 0.7 
Egypt 0.60 1.8 
El Salvador 0.59 2.1 
Equatorial Guinea 0.63 1.6 
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Eritrea 0.41 1.4 
Estonia 0.86 0.4 
Ethiopia 0.33 0.9 
Micronesia 0.58 0.8 
Fiji 0.64 0.7 
Finland 0.89 0.2 
France 0.86 0.5 
Gabon 0.65 1.6 
Georgia 0.70 0.7 
Germany 0.87 0.9 
Ghana 0.54 1.0 
Greece 0.82 0.9 
Greenland 0.76 0.3 
Grenada 0.64 1.1 
Guam 0.79 2.0 
Guatemala 0.52 1.3 
Guinea 0.32 0.9 
Guinea-Bissau 0.35 1.2 
Guyana 0.58 0.9 
Haiti 0.44 0.6 
Honduras 0.51 0.4 
Hungary 0.82 0.7 
Iceland 0.91 0.3 
India 0.55 1.5 
Indonesia 0.65 0.5 
Iran 0.70 1.1 
Iraq 0.58 1.3 
Ireland 0.88 0.5 
Israel 0.82 1.5 
Italy 0.84 0.7 
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Jamaica 0.68 0.7 
Japan 0.87 0.9 
Jordan 0.70 1.4 
Kazakhstan 0.74 0.5 
Kenya 0.50 0.7 
Kiribati 0.43 0.6 
Kuwait 0.79 2.0 
Kyrgyzstan 0.61 0.4 
Laos 0.52 0.8 
Latvia 0.83 0.6 
Lebanon 0.73 0.9 
Lesotho 0.49 1.2 
Liberia 0.33 0.6 
Libya 0.76 3.8 
Lithuania 0.84 0.5 
Luxembourg 0.92 0.9 
The Former Yugoslav Republic of Macedonia 0.75 1.0 
Madagascar 0.33 0.6 
Malawi 0.35 0.7 
Malaysia 0.76 1.1 
Maldives 0.66 0.2 
Mali 0.27 1.0 
Malta 0.84 0.8 
Marshall Islands 0.55 0.8 
Mauritania 0.47 1.1 
Mauritius 0.72 2.3 
Mexico 0.63 1.7 
Moldova 0.68 0.2 
Mongolia 0.66 1.0 
Montenegro 0.79 1.1 
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Morocco 0.58 0.6 
Mozambique 0.34 0.6 
Myanmar 0.56 1.2 
Namibia 0.62 0.6 
Nepal 0.43 1.6 
Netherlands 0.91 0.9 
New Zealand 0.84 0.3 
Nicaragua 0.53 1.1 
Niger 0.19 1.5 
Nigeria 0.49 1.0 
North Korea 0.54 0.6 
Northern Mariana Islands 0.76 1.2 
Norway 0.91 0.4 
Oman 0.74 1.7 
Pakistan 0.49 1.8 
Palestinian Territory 0.54 1.0 
Panama 0.68 0.5 
Papua New Guinea 0.42 0.7 
Paraguay 0.62 0.5 
Peru 0.64 0.6 
Philippines 0.62 1.2 
Poland 0.84 0.9 
Portugal 0.78 0.3 
Puerto Rico 0.81 1.0 
Qatar 0.77 3.6 
Romania 0.78 0.6 
Russian Federation 0.79 0.6 
Rwanda 0.41 0.9 
Saint Lucia 0.65 1.0 
Saint Vincent and the Grenadines 0.61 0.9 
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Samoa 0.58 0.6 
Sao Tome and Principe 0.49 1.4 
Saudi Arabia 0.78 5.4 
Senegal 0.37 1.1 
Serbia 0.75 0.9 
Seychelles 0.69 1.5 
Sierra Leone 0.36 0.7 
Singapore 0.87 1.8 
Slovakia 0.84 1.1 
Slovenia 0.86 0.6 
Solomon Islands 0.43 0.7 
Somalia 0.23 1.1 
South Africa 0.68 0.9 
South Korea 0.87 1.8 
South Sudan 0.27 1.4 
Spain 0.82 0.4 
Sri Lanka 0.68 0.4 
Sudan 0.48 1.0 
Suriname 0.64 1.4 
Swaziland 0.58 0.9 
Sweden 0.88 0.3 
Switzerland 0.89 0.6 
Syria 0.61 1.0 
Tajikistan 0.52 0.7 
Tanzania 0.41 0.8 
Thailand 0.68 1.0 
Bahamas 0.76 1.7 
Gambia 0.40 1.0 
Timor-Leste 0.50 0.5 
Togo 0.41 0.9 
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Tonga 0.62 0.7 
Trinidad and Tobago 0.70 1.4 
Tunisia 0.68 0.8 
Turkey 0.73 1.7 
Turkmenistan 0.70 0.9 
Uganda 0.39 1.0 
Ukraine 0.74 0.4 
United Arab Emirates 0.79 4.5 
United Kingdom 0.84 0.4 
United States 0.87 0.9 
Uruguay 0.71 0.2 
Uzbekistan 0.63 0.8 
Vanuatu 0.48 0.6 
Venezuela 0.66 0.8 
Vietnam 0.61 0.7 
US Virgin Islands 0.81 1.4 
Yemen 0.43 0.9 
Zambia 0.47 0.9 
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Figure S2: Plots of study data points against best fit model by modeling strategy where: 
A) only PM2.5 study data was utilized, and B) cross-sectional studies were de-weighted; and C) 
data from studies on proxy exposure were incorporated, and D) cross-sectional studies were 
de-weighted. The x-axis is the transformed value of the PM2.5 exposure contrast, a value based 
upon the input parameters of the specified model (here the set of parameters that achieved the 
best fit). The line represents the estimated beta coefficient. Points pertain to each data point and 







Supplementary material BMJ Global Health
 doi: 10.1136/bmjgh-2019-002063:e002063. 5 2020;BMJ Global Health, et al. Bowe B
55 
 











Supplementary material BMJ Global Health
 doi: 10.1136/bmjgh-2019-002063:e002063. 5 2020;BMJ Global Health, et al. Bowe B
56 
 











Supplementary material BMJ Global Health














Supplementary material BMJ Global Health
 doi: 10.1136/bmjgh-2019-002063:e002063. 5 2020;BMJ Global Health, et al. Bowe B
58 
 
Figure S3: Population attributable fraction of chronic kidney disease attributable to PM2.5 
in 194 countries and territories. Countries are colored by the population attributable fraction 
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Figure S4: Global burden of age-standardized incidence rate due to chronic kidney 
disease attributable to PM2.5 in 194 countries and territories. Countries are colored by the 
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Figure S5: Global burden of age-standardized prevalence rate due to chronic kidney 
disease attributable to PM2.5 in 194 countries and territories. Countries are colored by the 
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Figure S6: Global burden of age-standardized death rate due to chronic kidney disease 
attributable to PM2.5 in 194 countries and territories. Countries are colored by the age-
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